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(Order No.                  ) 
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                            Biophysics 
ABSTRACT 
 This dissertation is focused on developing cross-linking and mass spectrometry 
methodologies to study protein-protein interactions. Cross-linking, in combination with top-down 
mass spectrometry, provides advantages over bottom-up approaches, such as retaining 
posttranslational modifications. Intermolecular cross-linking studies focus on defining protein 
complex topology and protein-protein interactions. We first developed the top-down MS 
approach to analyze intermolecular cross-linking in human hemoglobin. Both α-α and β-β 
intermolecular cross-linking were found and the cross-linking sites on the protein were identified, 
obtaining distance constraints between subunits of the human hemoglobin protein complex. This 
methodology would be a promising approach to characterize protein complexes and protein-
protein interactions with high throughput and automation.  
This dissertation also focuses on development of cross-linking mass spectrometry to 
study Synphilin-1 interactors and aggresome formation. Synphilin-1 is a protein that promotes the 
formation of protein aggregates and aggresome formation upon proteasome inhibition, and is 
implicated in Parkinson disease. Synphilin-1 contains several protein binding motifs. The 
biological functions of Synphilin-1 and its role in aggresome formation and the pathogenesis of 
Parkinson disease remain to be elucidated. We utilized tandem affinity purification and label-free 
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mass spectrometry to explore the patterns of cellular proteins associated with Synphilin-1. We 
identified 57 Synphilin-1 interacting proteins, and functional enrichment and pathway analysis 
showed that many of the associated proteins are involved in chromatin modulation, RNA and 
protein metabolism. Furthermore, we developed a proteomic strategy to identify Synphilin-1 
binary interacting partners as well as interacting domains using affinity purification followed by 
isotopically tagged cross-linking in combination with mass spectrometry. We found 24 newly 
discovered proteins that directly bind to Synphilin-1. The proteins were mainly involved in RNA 
metabolism. The coiled-coil domain (CC), ankyrin-like repeat domain 2 (ANK2), and the protein 
aggregate promoting domain, appeared to the main regions that bound proteins. The functions of 
Synphilin-1 interacting proteins, such as CK2, in aggresome formation were studied. The results 
show that CK2 is an important regulator of aggresome formation, but not through its kinase 
activities. Involvement of Synphilin-1 in autophagy was also investigated. Knockdown of 
Synphilin-1 shows that Synphilin-1 impacts autophagy.  
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Chapter 1 : Introduction 
1.1 Mass spectrometry based proteomics 
1.1.1 Introduction 
Proteomics studies the protein complement of cells, including identification, modification, 
quantification, and localization
1
. Mass spectrometry (MS) uses mass analysis for protein 
characterization, and it is the most comprehensive and versatile tool in large-scale proteomics. 
Implementation of biological mass spectrometry requires a series of strategies (e.g. sample 
preparation, front-end separation, ionization, data acquisition, and data analysis) depending on the 
sample complexity and the goals of the analysis. The introduction reviews these strategies and 
their applications in this dissertation study. 
1.1.2 Ionization 
Proteins and peptides are polar, nonvolatile, and thermally unstable species that require 
an ionization technique that transfers an analyte into the gas phase without extensive degradation. 
The introduction of two soft ionization techniques, matrix-assisted laser desorption/ionization 
(MALDI)
2
, and electrospray ionization (ESI)
3
, paved the way for the modern MS proteomics. 
1.1.2.1 MALDI 
MALDI has advantages for the analysis of biomolecules due to its nondestructive 
vaporization and ionization, high sensitivity, and its tolerance for the presence of impurities, such 
as salts or detergents. The process of MALDI is illustrated in Figure 1-1. The analyte is co-
crystallized with a large molar excess of matrix compound that normally consists of a UV-
absorbing weak organic acid, such as 2,5-dihydroxybenzoic acid (DHB) or sinapinic acid (SA). 
The mixture is irradiated with a pulsed UV laser, such as a N2 laser (337 nm) or Nd:YAG laser 
(Y3: 355 mm), or an IR laser, e.g., Er:YAG laser (2.94 μm).  The MALDI matrix absorbs laser 
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energy and serves as a proton donor in the positive-ion mode, which ionizes the acidified analyte. 
The rapid laser heating causes desorption of matrix and [M + H]
+
 ions of analyte into the gas 
phase. MALDI-generated ions are predominantly singly charged. MALDI ionization usually 
requires several hundred laser shots to achieve an acceptable signal-to-noise ratio for ion 
detection
4
. The drawbacks are low shot-to-shot reproducibility and strong dependence on sample 
preparation methods
5
. A MALDI ion source is usually coupled to a pulsed analysis instrument. 
 
Figure 1-1. Scheme of matrix-assisted laser desorption/ionization producing gas phase ions. 
1.1.2.2 ESI 
Unlike MALDI, the ESI source produces ions from solution, and this property makes it 
capable of direct interface with high performance liquid chromatography (HPLC), and other 
continuous separation techniques
6
. Besides continuous-flow operation, compatibility with 
different types of solvents (e.g., acetonitrile, methanol, water), variability of flow rates, 
generation of multiply charged ions, make ESI a popular ionization method. An important 
development in ESI technique includes micro- and nano-ESI
7
, in which the flow rates are lowered 
to a nanoliter-per-minute regime to improve the sensitivity. Nano-ESI is compatible with 
capillary reversed phase (RP) columns
7b
 that offer higher sensitivity than traditional 2.1 and 1.0 
mm analytical columns
8
. There are several physical models of ESI ion formation
9
; the most basic 
design is illustrated in Figure 1-2. ESI is driven by high voltage (1-4kV) applied between the 
3 
 
 
emitter at the end of the spray needle and the inlet of the mass spectrometer. In the ESI process, a 
solution of acidic buffer containing the analytes is sprayed through a needle, and forms a Taylor 
cone
9c
. The cone emerges as a fine jet mist which breaks up into tiny charged droplets. As the 
solvent evaporates, the droplet shrinks until it reaches the point that the surface tension can no 
longer sustain the charge (the Rayleigh limit) at which point a "Coulombic explosion" occurs and 
the droplet is ripped apart. The resulting smaller droplets repeat this process until naked charged 
analytes form. Formation and desolvation of the droplets is aided by a heated capillary, and in 
some cases, by sheath gas flow at the mass spectrometer inlet. ESI is a soft ionization method as 
very little residual energy is retained by analytes upon ionization, and therefore even non-
covalent protein-protein interactions can be retained in the gas-phase.  
 
Figure 1-2. Electrospray ionization process. 
1.1.3 Fragmentation 
MS/MS involves the isolation and gas phase dissociations of selected precursor ions, 
followed by mass analysis of the resultant product ions. In certain types of mass spectrometry 
instrumentation, product ions can be subsequently isolated and then subjected to further 
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dissociation and mass analysis. This is termed MS
n
 analysis, where n represents the total number 
of isolation and mass analysis stages. Dissociation of a peptide can occur at the Cα-Ccarbonyl, 
Ccarbonyl-N (i.e., amide), or N-Cα bonds to give rise to a-, b-, or c-type “sequence” product ions if 
the charge is retained on the N-terminal segment and x-, y-, or z-type “sequence” product ions if 
the charge is retained on the C-terminal segment, as illustrated in Figure 1-3
10
. The amino acid 
sequence can be determined from the mass difference between consecutive product ions of a 
given (a-, b-, c-, x-, y-, or z) sequence. In addition to backbone fragmentations, the dissociation of 
amino acid side chains may occur. Although these ions are not indicative of the amino acid 
sequence, and are therefore termed “nonsequence” ions, they may indicate the amino acid 
composition. Importantly, the properties of the precursor ion (e.g., precursor ion polarity and 
charge state), and the dissociation methods, heavily influence the applicability of a given MS/MS 
dissociation method, and the type, structure, and abundance of the resultant product ions. 
A plethora of dissociation methods have been employed for the characterization of 
peptide ions, including collision-induced dissociation
11
 (CID; also known as collision-activated 
dissociation, CAD), higher-energy collisional dissociation
12
 (HCD), post-source decay
13
 (PSD), 
infrared multi-photon dissociation
14
 (IRMPD), ultraviolet photodissociation
15
 (UVPD), femto-
second laser-induced ionization/dissociation
16
 (fsLID), electron capture dissociation
17
 (ECD), 
electron transfer dissociation
18
 (ETD), electron ionization dissociation
19
 (EID), electronic 
excitation dissociation
17
 (EED), electron detachment dissociation
17
 (EDD), and metastable atom-
activated dissociation
20
 (MAD). CID, HCD, ECD, and ETD are most widely employed methods 
in the arsenal, and are used in this dissertation. Thus, they will be reviewed here in the 
introduction. 
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Figure 1-3. Nomenclature of peptide backbone fragment ions or sequence ions. Adapted 
from Ref. (10a, 21). 
1.1.3.1 CID & HCD 
To date, CID is the most widely used MS/MS method employed for peptide sequencing. 
In the CID process, precursor ions are collided with an inert target gas (e.g., He or Ar), which 
results in the conversion of ion translational energy into internal (vibrational) energy.  The 
acquired vibrational energy is quickly redistributed throughout the ion (≤10-12 sec), and the 
fragmentation of a particular bond occurs only when the vibrational energy exceeds the activation 
barrier of that bond. Since CID is under kinetic control and is a slow heating process
21
, 
fragmentation occurs most readily at the most labile bonds (i.e. amide bonds; the activation 
energy barrier of amide bond cleavage ~40 kcal/mol
22
), forming b- and y-type sequence ions. 
CID is compatible with many different mass analyzers, including quadrupole ion trap (QIT), 
quadrupole hybrid Fourier transform ion cyclotron resonance (QhFT-ICR), other quadrupole-
based collision cells, such as triple quadrupole (QqQ), quadrupole time of flight (qTOF), and 
TOF/TOF instruments. Higher-energy collisional dissociation (HCD) is a variation of the CID 
method introduced by Thermo Fisher Scientific
12
. This type of fragmentation is performed in a 
dedicated octopole collision cell at the far end of a C-trap, and is used in conjunction with the 
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orbitrap mass analyzer. HCD does not suffer from the low mass cutoff of resonant-excitation CID 
in an ion trap, and therefore is useful for isobaric tag-based quantification as low-mass reporter 
ions can be observed.  
Sustained off-resonance irradiation collision-induced dissociation (SORI-CID) is a CID 
technique used in Fourier Transform Ion Cyclotron Resonance mass spectrometry. In the process 
of SORI-CID, CID fragments results from accelerating the ions in cyclotron motion and 
increasing the pressure in the ICR cell. 
1.1.3.2 ECD & ETD 
Electron capture dissociation (ECD) involves exothermic capture of a low energy 
electron (~ 2 eV) by a multiply positively charged species followed by dissociation of the 
resultant odd electron ion
23
. Since the electron capture process requires low energy electrons (<10 
eV) and long interaction times, the application of ECD was traditionally confined to instruments 
that employ static electromagnetic fields that avoid energizing or heating electrons, such as FT-
ICRs. Recently, the addition of magnetic fields to ion traps has allowed for ECD in such 
electrodynamic trapping instruments
24
 and the use of ECD in a digital ion trap mass spectrometer 
has also been reported
25
. Protonated precursor ions with z ≥ 2 are required for ECD-MS/MS 
because charge reduction of a singly protonated precursor ion would result in an undetectable 
neutral species. ECD fragmentation of peptides results in the formation of c- and z-type product 
ions through radical reaction chemistry. A mechanism for the N-Cα cleavage has been proposed 
and is shown in Figure 1-4, where a H
•
 produced at the site of the initial electron capture is 
transferred to backbone carbonyl group followed by cleavage to form c- and z-ions. 
Electron transfer dissociation (ETD) is similar to ECD and induces the cleavage of the N-
Cα bond on a peptide’s backbone to produce c- and z- product ions. However, rather than 
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involving the direct capture of an electron, ETD involves transfer of an electron to the multiply 
protonated precursor ion from a singly charged radical anion. The use of electron donors makes 
ETD amenable for use in quadrupole ion trap mass spectrometers which utilize rf fields for 
simultaneous storage and reaction of ions with positive and negative polarities. Reagents with low 
electron affinities (<60-70 kcal/mol, e.g. anthracene, fluorathene, and azobenzene) have been 
used as electron donors for ETD. After electron transfer to a protonated peptide, the mechanism 
for dissociation at the N-Cα  bond is thought to be the same as that for electron capture (Figure 1-
4). 
 
Figure 1-4. Proposed fragmentation mechanism for the generation of c- and z-type product 
sequence ions for the reaction between a low-energy electron with a multiply protonated 
peptide ion. 
1.1.4 Instrumentation 
Mass spectrometers usually consist of the following components: the ion source and 
optics, the mass analyzer, and the data processing electronics. Mass analyzers are an integral part 
of each instrument because they can store and separate ions based on the mass-to charge ratios. 
Ion trap (IT), Orbitrap, and ion cyclotron resonance (ICR) mass analyzers separate ions based on 
their m/z resonance frequency, quadrupoles (Q) use m/z stability, and time-of-flight (TOF) 
analyzers use flight time. Each mass analyzer has unique properties, such as m/z range, analysis 
speed, resolution, sensitivity, ion transmission, and dynamic range. Hybrid mass spectrometers 
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combine more than one mass analyzer to answer specific needs during analysis. The different 
types of analyzer have been extensively reviewed
26
. The mass spectrometers used in this 
dissertation will be described as followed. 
1.1.4.1 Time-of-Flight (TOF) Analyzer 
The time-of-flight (TOF) analyzer is a pulsed analyzer and as such is routinely coupled 
with a MALDI ion source. Mass measurement in determined by measuring the time-of-flight of 
an ion in the analyzer region since the time-of-flight of an ion is proportional to the square root of 
its mass/charge ratio at a given a constant accelerating voltage: t=k(m/z)
1/2
. TOF analyzer 
resolution is limited by the flight tube length, as well as ion spatial, temporal and kinetic energy 
distributions. The TOF analyzer resolution can be improved by employing delayed extraction 
and/or a reflectron. 
The linear TOF analyzer is the simplest form and exhibits the lower performance with 
respect to resolution and mass accuracy. A linear TOF instrument is incapable of resolving the 
12
C and 
13
C isotopes of the peptide isotopic envelope across the range of the protein digest, 700-
3500 Da, and, subsequently, mass accuracy is poorer as the average mass, not the mono-isotopic 
mass, then must be used for database searching and peaks that are close in mass may contribute to 
the signal, thus shifting the observed peak center.  
Resolution is improved by delaying the extraction of ions from the source for a short 
period of time
27
. In delayed extraction, the application of acceleration voltage to the analyte ions 
is ceased for a short period of time (e.g. 400 nsec) and this allows ions to drift toward the flight 
tube based on their initial energy distribution. Then an acceleration voltage is applied therefore 
slower ions are accelerated more, enabling them to catch up to the faster ones. Energy focusing is 
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achieved by adjusting the amplitude of the extraction pulse and the delay between ion formation 
and extraction, which is mass dependent.  
A reflectron improves TOF resolution in two ways: (a) by acting as ion mirror reversing 
the trajectory of the ions in the flight tube, effectively increasing the length of the flight tube; (b) 
by reducing an ion’s kinetic energy spread. After formation in the ion source, ions of the same 
mass can have different kinetic energies when they leave the source depending upon their spatial 
position in the source when the accelerating voltage was applied, and, consequently, ions of the 
same mass can reach the detector at different times, thus reducing resolution and mass accuracy. 
A reflectron can correct this kinetic energy spread by allowing ions with higher kinetic energy 
penetrate the reflectron more deeply and thus ions with lower kinetic energy can catch up. This 
achieves better time-focusing of ions with the same mass at the detector, thus improving the 
resolution and mass accuracy.  
Delayed extraction coupled with a reflectron can routinely achieve resolution well above 
10,000 FWHM (Full width half maximum). This enables MALDI-TOF MS to be used reliably 
for protein identification in the 2D PAGE-MS workflow.  A TOF mass analyzer is commonly 
coupled with a pulsed MALDI source; orthogonal ion injection allows a TOF mass analyzer to be 
coupled to a continuous ion source, such as ESI, to build an ESI-TOF instrument. Before tandem 
TOF analyzers were readily available, the reflectron MALDI-TOF instruments were often with a 
technique called post source decay (PSD), which enables detection of the products from the 
metastable fragmentation that occurs between the ion source and the reflectron. Since the energy 
of the fragment ions is linearly related to the fraction of the precursor mass that they retain, 
different fragment ions require different reflectron voltage to be properly focused at the detector, 
thus, a PSD spectrum must be obtained by segments, which is time-consuming. To overcome this 
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drawback, a MALDI-TOF/TOF instrument was introduced for tandem MS (Figure 1-5), which is 
equipped with a collision cell. A MALDI-TOF/TOF instrument typically consists of a first source 
region for generating and extracting ions, a first TOF region that contains a timed ion selector 
(TIS) for precursor ion isolation and a collision cell for CID MS/MS, a second source region for 
accelerating fragmented ions,  followed by a second reflectron TOF region for ion detection. A 
TIS
28
 consists of a Bradbury-Nielsen dual gate, in which light ions are deflected by gate 1 and 
heavy ions are deflected by gate 2 to allow only ions of interest to pass through the dual gates and 
enter the collision cell. With its variety of operational modes, a MALDI-TOF/TOF instrument 
can be used for MS imaging, proteomic quantification with any label or label-free top-down and 
bottom-up workflow, glycoproteomics, and biopharmaceutical characterization. 
 
Figure 1-5. Schematic view of a MALDI-TOF/TOF instrument. 
1.1.4.2 Quadrupole mass analyzer 
The quadrupole analyzer consists of four parallel hyperbolic rods, through which the gas 
phase ions have to achieve a stable trajectory in order to be detected (Figure 1-6). The analyzer is 
operated by the application of a voltage (DC) and an oscillating voltage (radio frequency, rf) to 
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one pair of rods and DC voltage of opposite polarity and rf voltage of different phase to the 
opposite pair of rods. The alternating electric field helps to stabilize/destabilize the passing ions. 
The ions traverse through the space between the rods, and only at specific voltages applied to the 
rods will certain m/z values be allowed to pass through the rods and reach the detector. The 
voltages are scanned to allow ions to be observed sequentially over a wide m/z range. 
Quadrupoles offer three main advantages. They require only low fields and thus can be operated 
at relatively high pressures. Secondly, quadrupoles have a significant m/z range with the 
capability of analyzing up to an m/z of 4000. Access to this typical m/z range is useful because 
electrospray ionization of proteins and other biomolecules commonly produce charge 
distributions from m/z 1000 to 3500. Finally, quadrupole mass spectrometers are relatively low 
cost instruments. 
Because of its low resolution, a single quadrupole analyzer is not the first choice  for 
discovery proteomic analysis, but if three quadrupoles are arranged in sequence, the resulting 
triple quadrupole analyzer, coupled with ESI, has been demonstrated to be very useful for 
quantitative proteomics, when operated in the selected reaction monitoring (SRM) mode 
29
. The 
first and third quadrupoles operate as the mass filters and the second quadrupole serves as the 
collision cell.  
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Figure 1-6. Schematic view of a single quadrupole MS instrument. 
1.1.4.3 Ion trap 
The quadrupole ion trap (3D ion trap) is based on the same theory as the quadrupole 
analyzer. The ion trap is filled with helium and comprises a ring electrode and two end cap 
electrodes, creating the three dimensional electric field when a large rf voltage is applied to the 
ring electrode and a DC voltage is applied to the end cap electrodes (Figure 1-7). The orbiting 
motion of the ions in the trap is governed by the large rf voltage and the cooling effects of 
collisions with the helium gas, which reduces the kinetic energy of the ions and helps focus the 
ions in the center of the trap. When the rf voltage is scanned to make ion trajectories sequentially 
become unstable (from low m/z to high m/z), ions at the various m/z values over the operating 
range are selectively ejected and detected at the detector. 
Fragmentation of the precursor ion is caused by the application of a small voltage across 
the endcap electrodes and collisions with helium gas. A drawback of performing MS/MS in the 
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ion trap is that the upper limit on the ratio between precursor m/z and the lowest trapped fragment 
ion is ~0.3 (also known as the “one third rule”). There is a practical balance between the 
rerquirements that resonance excitation must be high enough to fragment the precursor ions but 
low enough to trap the maximum number of product ions, since low m/z ions will be ejected first. 
In addition, the dynamic range of ion traps is limited because when too many ions are in the trap, 
space charge effects diminish the performance of the ion trap analyzer. An advantage of mass 
spectrometers equipped with either quadrupole ion (Paul) traps and FT-ICR  traps  is the ability to 
perform multiple stages of mass spectrometry (MS
n
). 
Developments in ion trap technology have led to the linear quadrupole ion trap, where 
ions are trapped in a two-dimensional quadrupole field. The primary advantage to the linear trap 
over the 3D trap is that the larger analyzer volume lends itself to a greater dynamic range for both 
detection and quantification. 
 
Figure 1-7. Schematic view of an ion trap analyzer. 
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1.1.4.4 Fourier transform ion cyclotron resonance (FT-ICR) 
Similarly to an ion trap, a Fourier transform ion cyclotron resonance (FT-ICR) instrument 
is capable of trapping and storing ions (Figure 1-8). The ICR cell resides in a strong magnetic 
field and consists of three pairs of parallel plates arranged in a cube. When the ions enter the cell 
pressures are in the range of 10
-10
 to 10
-11
 mBar with temperatures close to absolute zero. The cell 
is located inside a spatial uniform static superconducting high field magnet (typically 4.7 to 13 
Tesla) cooled by liquid helium and liquid nitrogen. When the ions pass into the magnetic field 
they are bent into a circular motion in a plane perpendicular to the field by the Lorentz Force: 
F=zv*B (here F is the Lorentz Force observed by the ion when entering the magnetic field, z is 
the charge of the ion, v is the incident velocity of the ion, and B is the magnetic field strength). 
Ions are prevented from precessing out of the cell by the trapping plates at each end (Figure 1-8). 
In the cell, ions of a given m/z ratio have a specific cyclotron frequency and orbital radius: 
ωc=zB/2πm (here, ωc is the induced cyclotron frequency). At this stage, no signal is observed 
because 1) the radius of the motions is too small (e.g. 0.1 mm) to be detected by the detector 
plates, and 2) the signal can be cancelled out due to random distribution of ions in their different 
phases. Excitation of each individual m/z is achieved by a swept rf pulse across the excitation 
plates of the cell. Each individual excitation frequency will couple with the ions natural motion 
and excite them to a higher orbit where they induce an alternating current between the detector 
plates and pass through a resistor to generate a voltage signal. The frequency of this current is the 
same as the cyclotron frequency of the ions and the intensity is proportional to the number of ions.  
When the rf goes off resonance for that particular m/z value, the ions drop back down to their 
natural orbit (relax) and the next m/z packet is excited.  Although the rf sweep is made up of a 
series of stepped frequencies, it can be considered as all frequencies simultaneously. This results 
in the measurement of a complex frequency v.s. time spectrum containing all the signals. 
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Deconvolution of this signal by Fourier Transfer methods results in the deconvoluted frequency 
v.s. intensity spectrum, which is then converted to the mass v.s. intensity spectrum by m/z=B/2π 
ωc. FT-ICR MS affords high sensitivity, exceptional resolution, and mass accuracy.  
 
Figure 1-8. Schematic view of a FT-ICR analyzer. Here shows a square FT-ICR cell, but 
many modern FT-ICR cells are cylindrical. 
1.1.4.5 Orbitrap 
The Orbitrap traps ions in an electrostatic field, with the attraction towards a central 
electrode. The electrode confines the ions so that they orbit in complex spiral patterns. In the 
Orbitrap, stable ion trajectories combine rotation around an axial central electrode with harmonic 
oscillations along it. The frequency ω of these harmonic oscillations along the z-axis depends 
only on the ion mass-to-charge ratio m/z and the field curvature (k). Two split halves of the outer 
electrode of the orbitrap detect the image current produced by the oscillating ions. By Fast 
Fourier Transformation (FFT) of the image current, the instrument obtains the frequencies of 
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these axial oscillations and therefore the mass-to-charge ratios of the ions. The Orbitrap has been 
coupled with a linear ion trap or a quadrupole mass filter to form hybrid instruments, the LTQ-
Orbitrap™ and the Q-Exactive™, respectively..  
1.1.4.6 LTQ-Orbitrap-XL-ETD 
LTQ-Orbitrap-XL-ETD is an upgraded version of the hybrid LTQ-Orbitrap (Figure 1-9), 
which was first made commercially available by Thermo Fisher Scientific in 2005.  The original 
LTQ-Orbitrap contains an atmospheric pressure ion source (API), a linear ion trap (LTQ) for ion 
isolation, CID fragmentation, and ion detection, a C-trap between the LTQ and the orbitrap that 
injects ions into the orbitrap, and an orbitrap that employs FT for deconvolution of the measured 
rotational frequencies of the trapped ions to provide high resolution analysis. The XL version 
added an octopole dedicated for HCD collision, which does not suffer from the low mass cutoff 
of resonant-excitation CID and therefore is useful for isobaric tag-based quantification, as low-
mass reporter ions can be observed. The ETD (electron transfer dissociation) version added 
another module for ETD fragmentation. The ETD module generates radical anions, which are 
transferred to the linear ion trap to react with analytes for ETD fragmentation. The maximum 
resolution of this instrument is 100,000 at m/z 400. The mass accuracy is better than 2 ppm with 
internal calibration. Due to the ion trap feature, this instrument can perform MS
n
. The dynamic 
range is ≥ 4000:1.  
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Figure 1-9. Schematic view of the LTQ-Orbitrap-XL-ETD.  Adopted from LTQ-Orbitrap-XL-
ETD hardware manual. 
1.1.4.7 Q Exactive 
The Q Exactive (Thermo, CA) is a hybrid mass spectrometer that combines a quadrupole 
and an Orbitrap; it was introduced by Thermo Fisher Scientific at ASMS in 2011. It consists of an 
atmospheric pressure ion source (API), a stacked-ring ion guide (S-lens) in the source region, a 
quadrupole mass filter, a C-trap, an HCD cell, and an orbitrap mass analyzer as shown in Figure 
1-10. Ions are formed using an atmospheric ESI source, pass through a transfer tube to an S-lens 
and then via an injection multipole into a bent flatapole (a quadrupole with flat surface that has 
several advantage, such as reduced resonance and high transmission). After collisional cooling in 
the bent flatapole, ions are transmitted via a lens into a hyperbolic quadrupole, capable of 
isolating ions down to an isolation width of 0.4 Th at m/z 400. The quadrupole is followed by its 
exit lens combined with a split lens used to gate the incoming ion beam. A short octopole then 
brings ions into the C-trap interfaced to an HCD cell with axial field. The gas-filled HCD cell is 
separated from the C-trap only by a single diaphragm, allowing easy HCD tuning. Fragmentation 
of ions in the HCD cell is achieved by adjusting the offset of the rf rods and the axial field to 
provide the required collision energy. So long as this offset remains negative relative to the C-trap 
18 
 
 
and the HCD exit lenses, all fragments remain trapped inside the HCD cell, even if the offset of 
the rf rods is varied. This allows the introduction of multiple precursor ions and their fragments 
using optimum collision energy without compromising the storage of preceding injections. The 
summed ion population can then be transferred back into the C-trap, ejected into the orbitrap 
analyzer and analyzed in a single orbitrap detection cycle. This opens the possibility of new, 
“multiplexing” modes of operation. In practice, the useful number of ion injections for single 
orbitrap detection is limited by the sum of the individual inject times being lower than the time 
for the orbitrap scan. The resolving power of the Q Exactive is up to 140,000 at m/z 200. The 
maximum scan speed is 12 Hz at resolution setting of 17,500 at m/z 200. The mass accuracy is 
better than 1 ppm with internal calibration. The intra-scan dynamic range is ≥ 5000:1.  
 
Figure 1-10. Schematic view of the Q Exactive. Adopted from Ref. (31) 
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1.1.4.8 SolariX QqFT-ICR 
The SolariX is a hybrid Qq-FT-ICR Mass spectrometer constructed by Bruker 
Corporation (Figure 1-11); the instrument at BUSM is equipped with a 12-T shielded, cryogenic 
magnet. It consists of an ESI/MALDI dual source, a dual ion funnel for ion focusing and in-
source decay, a negative chemical ionization (nCI) source for ETD reagent anion generation (e.g. 
fluoranthene radical anions), an ion guide interfaced with quadrupole, a quadrupole for ion 
isolation, a collision cell for CID/ETD fragmentation, a hexapole to transfer ions to the ICR cell, 
an ICR cell surrounded by a refrigerated ultra-shielded magnet, and a source for electrons needed 
to produce ECD (electron capture dissociation). The SolariX has multiple fragmentation methods, 
including CID in the quadrupole collision cell, ECD, ETD, and sustained off-resonance 
irradiation (SORI) CID in ICR cell, which provide complementary sequence coverage. An 
infrared laser (CO2, 10.7 μm) can be used for heating or dissociation of trapped ions. ETD and 
ECD can preserve labile PTMs (Post-translational modifications) and are therefore particularly 
useful for study of protein conformational change due to PTMs, such as conformational charge of 
transthyretin (TTR) because of PTMs on Cys7. In addition, the SolariX has a feature called 
continuous accumulation of selected ions (CASI), which allows the low abundance ions of 
interest to be selected by the quadrupole and continuously transmitted to the collision cell. After 
the desired ion concentration is reached, the accumulated ions are subjected to high resolution 
analysis in the ICR cell. This feature can be used to enrich low abundance species, e.g. the 
products of chemical cross-linking reactions described below. The SolariX provides ultra-high 
mass resolving power (R > 1,000,000) and sub-ppm mass accuracy, making it well suited for top-
down MS analysis. 
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Figure 1-11. Schematic view of a SolariX hybrid Qq-FTMS. Adopted and modified from 
Bruker SolariX hardware manual. 
1.1.5 Separation methods prior to mass spectrometry analysis 
The complexity of biological samples requires many separation technologies to reduce 
sample complexity prior to mass analysis. Both accuracy and sensitivity of a mass spectrometric 
analysis rely on efficient separation.  In the first place, sufficient separation is required for 
unambiguous identifications of proteins and peptides without overlap of their m/z signals. Second, 
front-end separation is required to detect low-abundance species that would otherwise be 
overshadowed by the signals from higher abundance components. Two major sample separation 
approaches widely used in proteomics are gel-based and gel-free. Two-dimensional 
polyacrylamide gel electrophoresis (2D PAGE) has been used to separate protein samples based 
on their isoelectric focusing points and molecular weights
30
. Gel-based methods have been  
widely used with pulsed-ionization MALDI instruments in which the protein band can be excised, 
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digested, and off-line sampled with a MALDI source
31
. In contrast, high-pressure liquid 
chromatography (HPLC) is a continuous separation usually directly coupled to an ESI source, 
which can be interfaced with various scanning or trapping mass analyzers (LTQ, QqLIT, QqTOF, 
LTQ-Orbitrap, LTQ-FT-ICR, and Q Exactive). HPLC is distinguished from ordinary liquid 
chromatography (LC) because the pressure of HPLC is relatively high (~2000 psi), while 
ordinary liquid chromatography typically relies on the force of gravity to provide pressure. Due to 
the higher pressure separation conditions of HPLC, HPLC columns have relatively small internal 
diameter (e.g. 4.6 mm), are short (e.g. 250 mm), and packed more densely with smaller particles, 
which helps achieve finer separations of a sample mixture than ordinary liquid chromatography 
can. By using smaller particles (< 2 µm) and increasing pressure (~6000 psi), speed and peak 
capacity (number of peaks resolved per unit time in gradient separation) can be further improved, 
termed ultra-performance liquid chromatography (UPLC), which is a trademark of Waters 
Corporation.  HPLC/UPLC has become a standard front end for many biological applications and 
gave rise to several LC/MS configurations
26b, 26f, 32
.  Reversed-phase, hydrophilic-interaction 
chromatography (HILIC), ion exchange chromatography (IEX), size exclusion chromatography 
(SEC) are major types of HPLC/UPLC chromatographic materials are most commonly used in 
MS-based proteomics. A nanoACQUITY UPLC system (Waters, Milford, MA) is the main front-
end separation system used in the analyses described  in this dissertation. 
1.1.5.1 Reversed-phase chromatography (RPC) 
Reversed-phase (RP) chromatography separates compounds based on their 
hydrophobicity.  In reversed-phase columns, alkyl chains covalently bonded to the solid support 
create a hydrophobic stationary phase, which has a stronger affinity for hydrophobic compounds. 
As a result, hydrophilic molecules in the polar mobile phase (e.g. water/acetonitrile mixture) will 
be eluted first, and hydrophobic molecules will be eluted from the column by decreasing the 
22 
 
 
polarity of the mobile phase by using an organic solvent (e.g. acetonitrile), which reduces the 
hydrophobic interactions. The more hydrophobic the molecule, the more strongly it will bind to 
the stationary phase, and the higher the concentration of organic solvent that will be required to 
elute the molecule.  Thus, the proteins/peptides with different hydrophobicities can be separately 
eluted from the column by gradually decreasing the polarity of the mobile phase (e.g. by 
decreasing the ratio of water/acetonitrile). The most widely-used column resins are octadecyl 
carbon chain (C18)-bonded silica used for peptide separation, and butyl carbon chain (C4) for 
protein separation. The mobile phase of RPLC is compatible with ESI
33
, therefore RPLC is used 
as the single phase or as the last dimension of multidimensional separations before mass analysis. 
Increasing peak capacity, sensitivity, reproducibility, and analysis speed are major efforts that 
aim to improve the RPLC performance. 
1.1.5.2 Ion-exchange chromatography (IEX) 
Ion-exchange chromatography (IEX) is a process that allows the separation of ions and 
polar molecules based on their charge (ergo, their ionic interactions). The stationary phase 
surface displays ionic functional groups (R-X) that interact with analyte ions of opposite charge.  
IEX is subdivided into cation exchange chromatography and anion exchange chromatography. 
IEX has strong and weak exchange materials (e.g. carboxylic acid for weak cation exchange, 
primary amine for weak anion exchange, sulfonic acid for strong cation exchange, quaternary 
amine for strong anion exchange). A resin or gel matrix of IEX consists of agarose or cellulose 
beads with covalently bonded charged functional groups. The target analytes are retained on the 
stationary phase but can be eluted by increasing the concentration of a similarly charged species 
that will displace the analyte ions from the stationary phase. Proteins have numerous functional 
groups that can have both positive and negative charges. IEX separates proteins according to their 
net charge. Trypsin digested peptides with basic C-termini can also be separated using strong 
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cation exchange (SCX). SCX is employed in this dissertation to enrich cross-linked peptides due 
to their higher basicities.  
1.1.5.3 Size-exclusion chromatography (SEC) 
Size-exclusion chromatography (SEC), also known as gel permeation chromatography or 
gel filtration chromatography, separates particles on the basis of molecular size. SEC works by 
trapping smaller molecules in the pores of a particle while larger molecules pass through since 
they are too large to enter the pores. Thus, SEC can be used for separate proteins with different 
molecular weights. SEC is employed in this dissertation to separate cross-linked dimers from 
unmodified proteins.  
1.1.5.4 Multidimensional separation 
High-complexity large-scale proteomic samples contain thousands of proteins that can 
range upward of five orders of magnitude in their abundance
34
. The complexity of the shotgun 
proteomic samples is even higher because each proteolytically digested protein yields multiple 
peptide products. Multidimensional separation approaches combine several separation techniques 
based on different molecular properties to improve the resolving power, and therefore reduce 
sample complexity. As an example, SCX chromatography followed by RPLC is frequently 
employed in shotgun proteomics, in an approach that has been termed multidimensional protein 
identification technology (MudPIT)
34b, 35
. 
1.1.6 Proteomic approaches 
There are two approaches for proteomic analysis: bottom-up and top-down. In the 
bottom-up approach, the proteins are enzymatically digested into peptides. In the top-down 
approach, the intact proteins are analyzed.  
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1.1.6.1 The bottom-up approach 
Bottom-up proteomics is an approach in which proteins are proteolytically digested into 
peptides prior to mass analysis, and the ensuing sets of peptide masses and their MS/MS-
determined sequences are used to identify the corresponding proteins. Previously, peptide mass 
fingerprinting (PMF) aimed to identify proteins by measuring the masses of their proteolytic 
peptides and correlating the pattern with the theoretical masses computed from gene/protein 
sequences in databases
36
. PMF is usually employed with gel-based separation to reduce sample 
complexity and followed by MALDI-TOF MS analysis, although LC-ESI MS can also be used 
for this purpose. Many algorithms for PMF identification are available and have been reviewed.  
At the present time, tandem MS has become the most widely used bottom-up proteomics 
approach; in this method, peptides of interest are subjected to fragmentation (e.g. CID, ETD, and 
ECD). The experimental MS
n
 data are compared with the predicted, in silico-generated 
fragmentation patterns of the peptides predicted from the databases. A large number of algorithms 
have been developed for making rapid, automated assignments of peptides and proteins based on 
MS/MS data, such as MASCOT (Matrix Science, UK)
36
 and SEQUEST
37
. Each of these has its 
own particular properties, such as scoring schemes. Many commercially or publicly available 
programs integrate with these algorithms to increase the overall sequence coverage and reliability, 
such as Proteome Discoverer (Thermo Fisher Scientific, CA). The bottom-up approach is well 
suited for chemical modification of peptides, with the aim of peptide of protein quantification, 
such as, ICAT (isotope-coded affinity tag)
38
, 
18
O labeling
38-39
, TMT tag (tandem mass tag)
40
, and 
iTraq tag (isobaric tag for relative and absolute quantitation)
41
. 
The advantages of the bottom-up approach include better front-end separation of peptides, 
as compared with proteins, and higher sensitivity than the top-down method. Drawbacks of the 
bottom-up approach include limited protein sequence coverage by identified peptides, loss of 
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labile PTMs, ambiguity of the origin for redundant peptide sequences and loss of information on 
the temporal and functional relationships among PTMs that occur on different peptides.  
1.1.6.2 The top-down approach 
The top-down approach use masses of intact proteins and their fragments for protein 
identification and structural characterization. Alternative fragmentation reactions, such as ECD
23
 
and ETD
42
, which yield more complete backbone sequencing and retain labile PTMs
43
, are the 
preferred fragmentation methods for the top-down approach. The benefits of the top-down 
approach include higher sequence coverage
44
 and better characterization of the PTMs
45
, which 
allow for identification of the specific protein isoforms
46
. Another advantage of the top-down 
approach is improved reliability of protein quantification
47
 when protein abundances are 
measured directly instead of using the abundances of peptides. However, there are several 
technological limitations to the top-down method. First, front-end separation of intact proteins is 
more challenging than the separation of peptide mixtures. Secondly, larger quantities of protein 
and higher resolution and higher mass accuracy instruments such as FT-ICR MS
48
 and Orbitrap
47a, 
49
 are required to resolve and correctly assign the isotopic envelopes of coeluting proteins and the 
very large numbers of product ions. Thirdly, although some proteins yield highly informative 
fragmentation patterns, efficient methods for fragmentation of all large proteins are not readily 
available. Therefore, the scope of the top-down approach has largely been limited to the analysis 
of single proteins and simple protein mixtures. 
1.1.7 Quantitative proteomics 
Following the establishment of the qualitative level of protein analysis by MS, 
quantifying the functional entities of the cell, the proteins, is the next stage of large-scale 
proteomic for systems biology. The overall goal of such measurements is to obtain a snapshot of 
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concentrations of proteins (and ideally, all proteoforms) associated with different states. However, 
MS is a technique for the measurement of mass-to-charge ratios of charged species and variations 
in the ionization efficiencies among proteins or their proteolytic peptides mean that the raw data 
do not provide quantitative information of the charged species. Owing to the different 
physicochemical properties of different peptides and proteins, their signals in the mass 
spectrometer cannot be used for quantitative comparisons between different molecular species. 
Quantification relies mainly on comparison of the ratios of the same molecules in different 
experiments, or comparison within a single experiment of molecules that differ only in their 
isotopic composition and therefore have identical physical and chemical properties.  
There are a variety of quantitative proteomics methods. They can be classified into two 
groups based on the desired quantitative information: (a) relative quantification, comparing the 
amounts of proteins or whole proteomes between samples and yielding a quantitative ratio or 
relative change, and (b) absolute quantification, measuring the absolute amount or the 
concentration of a protein within a sample. They can be also divided into two groups by the 
underlying methodology: (a) stable isotope-labeling quantification involving the in vivo or in 
vitro labeling of peptides and proteins, and (b) label-free quantification, in which the samples 
retain their native isotope compositions and their signal abundances are compared between 
separate experiments.  
Label-free quantification has the advantage of allowing the quantification of a virtually 
unlimited number of samples (multiplexing) without any chemical, metabolic, or enzymatic 
modification; this lowers the costs and minimizes the number of sample-handling steps. However, 
label-free quantification relies on highly reproducible sample-handling, separation by liquid 
chromatography and MS measurements. The often-poor reproducibility may require analysis of 
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many technical replicates and may lead to low accuracy of the quantitative measurements. These 
limitations led to the development of quantification methods that use stable isotope labeling. 
Peptides and proteins contain several naturally occurring stable heavy isotopes (e.g., 
13
C, 
15
N, 
18
O, 
2
H).   The natural abundances of these heavy isotopes in peptides/proteins are reflected in the 
isotope patterns observed in the mass spectra. Deliberate incorporation of heavy isotopes 
produces a mass shift of the peptide/protein peaks in the mass spectra. Importantly, additional 
13
C, 
15
N, and 
18
O have little or no impact on the behavior of peptides and proteins during LC or in the 
mass spectrometer. Thus, the intensity ratios of peaks that correspond to different isotopic 
compositions of the same molecular species provide quite reliable quantitative information of the 
proportion of each species in different measurements. Labeling techniques take advantage of this 
feature and allow direct comparison of two or more samples within the same mass spectrum. 
Label-based approaches offer a higher accuracy of quantitative measurements, but they require 
additional steps in sample preparation and usually entail significantly higher costs, when 
compared with label-free approaches. Additionally, only a limited number of samples can be 
quantified within one experiment (from two to eight, depending on the method). Quantitative 
information can be obtained, not only from comparing intact peptide/protein peak intensities in 
the MS spectra, but also from the MS/MS spectra. The advantages of the former are that usually 
more than one independent spectrum is available for analysis, and also that the high peak 
intensity gives statistically more accurate results. Quantification of the fragment ion spectrum 
benefits from the absence of overlapping precursor ion peaks (as in selected reaction monitoring, 
SRM) and from the identical properties of the precursor ion (as in iTRAQ).  
Various labeling and label-free methods have been developed for quantitative proteomics. 
Methods for absolute quantification include AQUA (absolute quantification)
50
, emPAI 
(exponentially modified protein abundance index)
51
, APEX (absolute protein expression 
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measurements)
52
, and Top3 (top3 quantification)
53
. Methods for relative quantification contain 
ICAT (isotope-coded affinity tags)
54
, ICPL (isotope-coded protein label)
55
, dimethyl labeling
56
, 
iTRAQ (isobaric tag for relative and absolute quantitation)
40
, TMTs (tandem mass tag)
41
, 
15
N 
labeling
57
, SILAC(stable isotope labeling with amino acids in cell culture)
58
, 
18
O labeling
39, 59
, 
spectral count
60
, and ion-current measurements
36, 61
.  These methods, as well as corresponding 
software tools for quantitative mass spectrometry-based proteomics, has been well reviewed
62
. 
The most widely used relatively quantitative proteomics methods and software tools are reviewed 
below. 
1.1.1.1 Label-free quantitative proteomics 
Label-free methods fall into two general categories: (a) ion peak intensity methods that 
involve comparing peptide signal intensities at the level of LC-MS analysis, and (b) spectral 
counting methods that involve counting the number of identified peptides or acquired fragment 
spectra. 
In the absence of signal suppression, peak intensities of ions after electrospray ionization 
correlate with ion concentrations
36, 61
. Therefore, the extracted peak areas of specific 
peptides/proteins from LC-MS chromatograms (extracted ion chromatograms, XIC) can be used 
for relative quantification of the peptides and proteins between different samples. The method 
allows measurements with high precision and wide dynamic range, especially when nanoflow 
rates and high-resolution mass spectrometers are used. It can also be applied to MALDI 
measurements that are combined with offline-LC separation. There are three critical steps in data 
processing: (1) at least three biological and/or technical replicates should be performed to ensure 
reproducibility, (2) the LC retention time and m/z values of identical peptides should be aligned 
between LC runs, and (3) the variation between measurements of the peak intensities of peptides 
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from the same sample (technical replicates) should be normalized. Practical normalization 
strategies may include the addition of identical amounts of standard protein in different sample or 
normalization, based on a priori information about a protein that does not change quantitatively 
between the samples that are being compared
63
. Reproducibility of LC separation, stability of the 
electrospray ion source, and the use of computational algorithms for comparison, alignment, and 
statistical evaluation of several LC-MS datasets in a single procedure are therefore crucial. In this 
dissertation, Progenesis LC-MS (Nonlinear Dynamics, Durham, UC, USA) was used for 
peptide/protein quantification. The work flow of Progenesis LC-MS is shown in Figure 1-12. 
Briefly, LC-MS/MS data are imported into Progenesis LC-MS to generate a 2-dimensional map 
using retention time and m/z as axes. Then, all peaks that are identical in the different LC runs 
(e.g. biological and/or technical replicates) are aligned. The ions can be filtered based on their RT, 
m/z, and charges. The selected ion peaks will be normalized across all samples. The samples are 
grouped according to experiment sets. The peptide peaks with MS/MS information can be 
exported to MASCOT for protein identification. For the identified proteins, statistical analysis 
can then be performed to compare proteins between samples, such as fold change and ANOVA 
(Analysis of variance) p-value.  
 
Figure 1-12. Data processing work flow of Progenesis LC-MS for label-free quantification. 
The second category of label-free quantification methods relies on the practical 
observation that more abundant peptides are more likely to be observed and detected in an MS 
experiment. It has been found that a linear correlation over two orders of magnitude between the 
number of spectra and the relative protein abundance, whereas no correlation between the relative 
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protein amounts and the number of peptides and the sequence coverage was observed
60
. These 
approaches use the number of fragment spectra observed for a particular protein in the analysis. 
Normalization and careful statistical evolution are still required for accurate quantification even 
though spectral counting is a relatively simple and reliable method. The accuracy can decrease 
significantly for proteins with only a few observable peptides, or when the quantitative changes 
between experiments are small
64
. Furthermore, since larger proteins give rise to more peptides 
than do smaller ones, additional normalization factors can be applied to improve the results of 
quantification
65
. The commonly used software tools, such as Scaffold 3. 
1.1.7.1 Labeling quantitative proteomics 
Stable isotope labeling methods for relative quantification make use of labeling by stable 
heavy isotopes of  
13
C, 
15
N, 
18
O, 
2
H. The isotope labels can be introduced (a) metabolically, (b) 
chemically, or (c) enzymatically.  
Metabolic labeling with stable heavy isotope labels introduces the label at the earliest 
time point in an experiment, i.e., during cell growth and duplication. This is achieved by feeding 
organisms with special media containing relevant precursors in heavy labeled form. Metabolic 
labeling ensures lower deviations in quantification, as the samples to be compared can be mixed 
at a very early stage during the experiment. The most widely used metabolic labeling is stable 
isotope labeling by amino acids in cell culture (SILAC)
58
. In the SILAC method, cells (or intact 
small organisms) are fed with lysine and arginine that contains different numbers of the heavy 
isotope 
13
C, 
15
N, and 
2
H to build proteins under the culture conditions. The proteins are then 
detected in labeled and unlabeled form for quantification. Digestion of the labeled proteins with 
trypsin results in peptides that contain at least one labeled amino acid (except for the C-terminal 
peptide of the protein). The quantitative information can be obtained by comparison of the 
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intensities of the precursor isotope envelopes for unlabeled and labeled peptides, especially with 
the assistance of computational tools, such as MaxQuant. SILAC can be used to compare two or 
three samples simultaneously. It has been applied successfully in near–whole proteome 
quantification profiling
66
, in separating background from specific interactors in pull-down 
approaches
67
, and in following dynamic changes in response to stimuli
68
. Other than cell culture, 
SILAC has been applied to whole organisms such as Drosophila
69
 or mice
70
. However, 
incomplete labeling and metabolic conversion of arginine to proline results in the production of 
tryptic peptides that contain heavy prolines
71
 and this will result in inaccurate quantification, 
which needs to be minimized by experimental or bioinformatics solutions
72
. A significant 
drawback of metabolic labeling methods is their very limited practicality for quantifying tissues 
and body fluids from whole organisms.  
The methods for relative quantification by chemical labeling rely on the chemical 
reaction (without enzymatic catalysis) between a reagent and the peptides (or proteins) in the 
sample of interest in vitro (i.e., after isolation of the protein/peptide from the biological sample). 
The reagents bear different numbers of stable heavy isotopes and thus produce a mass shift in the 
MS spectrum (e.g., dimethyl labeling) or MS/MS spectrum (in case of isobaric reagents, e.g., 
iTRAQ). ICAT reagents (isotope-coded affinity tags)
54
 provided one of the first chemical labeling 
approaches for proteomics. The ICAT chemical label consists of three moieties: a sulfhydryl-
reactive group for coupling to cysteines on peptides, an affinity group for isolation of the tagged 
species (peptides), and a linker in light (with natural isotope distribution) and heavy (containing 
eight deuterium atoms instead of 
1
H) form. Two samples to be compared are labeled with light or 
heavy ICAT reagent and subsequently mixed. After analysis, the peak intensities of identical 
peptide pairs labeled with the light and the heavy reagent, respectively, are compared, and their 
ratio is calculated. Significant disadvantages of the approach are the side-reactivity of the tag and 
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its inability to label peptides lacking cysteine. Another labeling method based on the same 
principle is ICPL (isotope-coded protein labels
55
. A significant advantage of ICPL is their 
reactivity towards free amines, allowing labeling of virtually all peptides present in the samples. 
Dimethyl labeling is a similar approach using simpler chemical reagents
56, 73
. In this method, 
dimethylation of lysine residues by stable-isotope-labeled formaldehyde and cyanoborohydride 
allows duplex and triplex relative comparison. This approach offers a reliable and inexpensive 
alternative to the common chemical labeling methods, while accomplishing nearly 100% labeling 
efficiency in a simple chemical reaction. mTRAQ (Applied Biosystems) is a recent addition to 
the repertoire of amine-reactive labels. It uses double or triple labeling by stable heavy-isotope-
labeled chemical reagents and is designed to be used in SRM assays. It is specifically applied in 
biomarker discovery experiments as alternative to labeled standard peptides
74
. 
An important group of reagents used for relative quantification comprises the isobaric 
chemical labels. These rely on isobaric labeling of peptides from different samples, which upon 
fragmentation give rise to different reporter ions in the MS/MS spectrum. For example, the 
iTRAQ
40
 (isobaric tags for relative and absolute quantification) contain an amine-reactive group, 
a balance group, and a reporter group. The isobaric tags contain different distribution of heavy 
isotopes between the balance and reporter groups but have the same molecular weight, and 
therefore, upon labeling, produce identical mass shifts. Thus, identical peptides from different 
samples to be compared co-elute and are detected as a single precursor ion. The relative 
abundances of the isobaric components, however, are proportional to the intensities of the 
reporter groups upon MS/MS fragmentation. A major advantage of this method is that multiple 
variants of the labeled reagents are available and therefore iTRAQ has the capability for 
“multiplexing” (i.e. up to eight samples can be analyzed within a single experiment). 
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A very similar approach is the labeling with tandem mass tags (TMTs, Thermo 
Scientific
41
), which allows comparison of up to six samples. Like iTRAQ tags, TMTs also consist 
of an amine-reactive, a balance, and a variable stable-isotope labeled reporter group which is 
released upon fragmentation during MS/MS, the intensities of whose signals are used to calculate 
relative amounts between the samples. 
A different approach for quantification at the MS/MS level is IPTL (isobaric peptide 
termini labeling
75
. This uses isobaric sequential labeling of the C- and N termini of the analyzed 
peptides with deuterated and non-deuterated reagents. Upon fragmentation, either the N-terminal 
or the C-terminal label is lost, and this results in differentially labeled C- and N-terminal fragment 
ion series, respectively. These appear as fragment ion pairs in MS/MS and their relative signal 
intensities can be used for quantification. An advantage of this strategy is that the quantification is 
based on several data points per MS/MS spectrum, although this complicates data analysis 
enormously. 
A significant advantage of all chemical labeling methods is that they can be applied to 
practically any type of sample (cell culture, tissues, body fluids, etc.), in contrast to metabolic 
labeling as discussed above. However, it is crucial to optimize labeling conditions. 
Heavy stable isotopes can be incorporated during enzymatic proteolysis of proteins. 
Performing proteolysis in heavy (H2
18
O) or light (H2
16
O) water incorporates, respectively, two 
18
O 
or 
16
O atoms at the C terminus of the generated peptides, resulting in a mass difference of 4 Da 
between heavy- and light-labeled peptides
50a, 59
. This label can also be incorporated after digestion 
in a second incubation step with a protease. This method ensures near-complete labeling and 
benefits from the absence of side reactions. 
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1.2 Cross-linking combined with mass spectrometry for structural proteomics 
Physical interactions between proteins and the formation of stable complexes underlie 
most biological functions. Therefore, determination of the structures of protein complexes 
illuminates their function and contributes to understanding of the pathways of the cellular 
machinery. To determine the structures of the protein complexes, a series of several types of 
information should be acquired, such as protein identifications, stoichiometry, subunit structures, 
subunit-subunit interactions, assembly topology, assembly packing, and complex structure
76
. A 
variety of methods have been used to determine the structures of protein complexes, including X-
ray crystallography and nuclear magnetic resonance (NMR), cyro-electron microscopy, small-
angle X-ray scattering and labeling techniques. Mass spectrometry is another emerging structural 
biology approach which can be used to determine composition, stoichiometry, protein interaction, 
and assembly topology of a protein complex. Chemical cross-linking in combination with mass 
spectrometry is a sub-category of MS-based structural biology which is mainly used to elucidate 
protein structure and protein-protein interactions. 
1.2.1 Bottom-up and top-down cross-linking approaches 
There are two alternative strategies to perform cross-linking mass spectrometry, the 
bottom-up approach and the top-down approach (Figure 1-13). In the bottom-up approach, after 
the cross-linking reaction, cross-linked proteins are either separated by SDS-PAGE and followed 
by in-gel digestion, or separated by size-exclusion chromatography and followed by in-solution 
digestion. The resulting peptides are analyzed by MALDI-TOF MS or online-LC-MS/MS to 
identify cross-linking residues. The most commonly employed cross-linking reagents react with 
primary amine groups at lysine residues and N-termini; this property results in two limitations of 
the bottom-up strategy. First, missed cleavages occur because the most commonly used 
proteolytic enzyme, trypsin, cannot recognize and cleave at the C-terminal of modified lysines. 
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Second, cross-linked modified species tend to carry low charge states during ESI due to a loss of 
positive charge after modification of the ε-amino groups of lysine residues. In the top-down 
approach, cross-linked intact proteins are directly injected into the MS. This approach replaces 
SDS-PAGE separation or size-exclusion chromatography with gas-phase protein ion isolation, 
and replaces proteolytic digestion with gas phase ion fragmentation, and therefore enables high 
throughput and automation for determination of protein sequence and localization of 
modifications. Also, the top-down approach eliminates the artificial gain or loss of protein post-
translational modifications during chromatographic separations and/or proteolytic digestion steps. 
However, because the top-down approach requires a high resolution, high sensitivity mass 
spectrometer and optimized cross-linking methodologies, only intramolecular cross-linking 
results have been published. 
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Figure 1-13. Bottom-up and top-down approaches for protein structure characterization by 
chemical cross-linking and mass spectrometry. 
1.2.2 Cross-linking reactions  
Chemical cross-linking reactions form covalent bonds between different molecules 
(intermolecular) or within parts of a molecule (intramolecular). A canonical cross-linker, by 
definition, contains two reactive groups connected by a spacer. The inclusion of additional 
functionalities, such as cleavable groups and affinity groups, could facilitate successful 
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downstream mass spectrometric analysis. The use of isotope-labeled cross-linkers can facilitate 
identification of cross-linked peptides and assignments of cross-linked peptide fragments. 
1.2.2.1 Reactive groups 
Although there are 20 common amino acids, only four protein functional groups can 
serve as cross-linking targets, primary amines (e.g. lysine and N-terminus), carboxyl groups 
(aspartic acid, glutamic acid, and C-terminus), sulfhydryl groups (cysteine) and carbohydrate 
groups (glycoproteins). The most common targets are thiol and primary amine nucleophilic 
groups which can be gently and selectively modified without changing the native conformation of 
the protein.  
N-hydroxysuccinmie (NHS) is the most widely used among the acylating reagents which 
react with primary or secondary amines to form stable amide and imide bonds (Figure 1-14A). 
Many NHS esters are insoluble in aqueous buffers, therefore they must be dissolved in an organic 
solvent and diluted into the aqueous reaction medium. Alternatively, sulfo-NHS esters are water 
soluble. NHS esters exhibit 1-2 h life-times under physiological pH conditions (pH 7.0-7.5) with 
hydrolysis and amine reactivity increasing when the pH is raised. The reaction of NHS esters with 
sulfhydryl groups (in cysteines) or hydroxyl groups (e.g., in serine or threonine) does not yield 
stable products because the thioester or ester products hydrolyze rapidly in aqueous solution. 
Imidazole nitrogens of the histidine ring may also be acylated by NHS esters, but the reaction 
products are also rapidly hydrolyzed
77
. 
An imidoester is one of the most specific acylating groups to modify primary amines 
(Figure 1-14B). It reacts at the N-terminus of the protein as well as the ε-amino groups in lysine 
side chains at pH between 8 to 9. Imidoesters are highly water soluble, but undergo continuous 
degradation due to hydrolysis, which reduces the half-life of the imidate group to less than 30 
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min
78
. The reaction product of the imidoester, an amidine, is protonated and carries a positive 
charge at physiological pH. This retains the positive charge of the lysine group, thus avoiding the 
distortion the three-dimensional structure caused by removing the positive charge at lysine 
residues involved in the cross-linking reactions.  Under physiological pH, an imidoester has 
modest cross-linking efficiency compared to NHS
79
. 
Maleic acid imides (or maleimides) are widely used groups reactive to sulfhydryls 
(Figure 1-14C). Maleimide reactions are sulfhydryl-specific in the pH range between 6.5 and 7.5, 
and at pH 7 the reaction with maleimides proceeds1,000-times faster with sulhydryls than with 
amines. At more basic pH values, however, reactions with amines may also take place. 
Hydrolysis of the maleimide group may occur, especially at higher pH, to create an open 
maleamic form, which is non-reactive towards sulfhydryl groups. 
 
Figure 1-14. Reaction schemes of the most commonly used reagents for cross-linking of 
proteins. (A) NHS esters (amine-reactive), (B) imidates (amine-reactive), (C) maleimides 
(sulfhydrylreactive). Adapted from (82). 
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1.2.2.2 Cross-linking reactions 
Cross-linkers react with proteins to form three types of products (Figure 1-15), inter-
protein cross-linking, inter-protein loop-linking, and mono-linking. Inter-protein cross-linking is 
formed by cross-linker bridging between residues on two protein molecules. Intra-protein cross-
links are generated by a cross-linker connecting two reactive sites on the same protein molecule. 
Mono-linking is created by one reactive end of the cross-linker attaching to the protein while the 
other reactive end is hydrolyzed to form a free-arm. Inter-protein cross-linking provides useful 
information about protein-protein interactions. Using enzymic digestion followed by LC-MS/MS 
or top-down protein fragmentation, both the cross-linked protein/peptides and the cross-linking 
sites can be determined, and this information defines binary interacting partners and their 
interacting domains. This enables determination of protein complex assembly topology and thus 
helps to elucidate protein functions. Intra-protein looping gives insight into protein topology and 
structural information based on the distance proximity data provided by the known spacer length 
of the cross-linker.  Mono-linking reveals accessibility of protein residues since the residues on 
protein surfaces are more likely to react with cross-linkers. 
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Figure 1-15. Three types of products of protein cross-linking reaction. (A) inter-protein cross-
linking, (B) intra-protein loop-linking, and (C) mono-linking. 
1.2.3 Cross-linker designs 
There are five types of cross-linkers, homobifunctional cross-linkers, heterobifunctional 
cross-linkers, cleavable cross-linkers, trifunctional cross-linkers, and isotopically tagged cross-
linkers (Figure 1-17). Homobifunctional cross-linking reagents contain identical functional 
groups at both reactive sites, which are connected with a carbon-chain spacer that bridges a 
defined distance (e.g. 11Å), and allows identical functional groups on the protein(s) (e.g. amine 
or sulfhydryl groups) to be cross-linked. The heterobifunctional cross-linking reagents contain 
two different reactive groups that target different functional groups on proteins (e.g. an amine and 
a sulfhydryl group). Those cross-linking reagents are used to cross-link proteins; they require 
two- or three-step protocols due to different reaction conditions and/or accessibility for different 
reactive groups. Heterobifunctional cross-linkers that contain one photo-reactive group offer 
additional advantages, because the photoreactive group is stable until it is exposed to high 
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intensity UV light. Both homobifunctional cross-linkers and heterobifunctional cross-linkers can 
eliminate the spacer arm and mediate cross-linking between two proteins by creating a bond 
without an intervening linker; this feature creates a special class of cross-linkers termed “zero-
length cross-linkers” The most widely used type of zero-length cross-linkers are probably the 
carbodiimides which are applied to mediate amide bond formation between a carboxylate and an 
amine group.  
Due to the low yield of cross-linking reactions (~10-20%) and the presence of much more 
abundant hydrolyzed mono-linking species, the detection of low abundance inter-protein/peptide 
cross-linking becomes a challenge equivalent to “finding needles in a haystack”.  Therefore, a 
number of strategies have been developed that aim to facilitate the identification of cross-linked 
products by introducing discriminating properties or by enriching cross-linker-containing species, 
using specific tags.  
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Figure 1-16. Different types of cross-linking reagents. (A) Homobifunctional cross-linkers, (B) 
heterobifunctional cross-linkers, (C) cleavable cross-linkers, (D) trifunctional cross-linkers, and 
(E) Isotopically tagged cross-linkers. 
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1.2.3.1 Cleavable groups 
Cleavable cross-linkers become valuable for structural assignments because, after 
cleavage, the cross-linked peptides behave like regular peptides containing a certain mass shift 
and this feature makes it possible to use current protein databases. Cleavage of the cross-linker 
can be provided by incorporating a chemically, photo-, or MS-cleavable group into the structure 
of the cross-linking reagent. Chemically-cleavable groups should allow cleavage reactions which 
are specific to the cross-linker and which can be initiated under mild conditions without 
disrupting amino acid residues or peptide bonds. Use of MS-compatible volatile cleavage 
reagents such as mercaptoethanol (for the reduction of a disulfide group) or ammonia (for base 
hydrolysis of an ester bond) is beneficial because this allows the cleavage reaction to be 
performed directly on a MALDI-MS target spot or in a sample solution for ESI-MS analysis. 
Photo-cleavable groups allow cleavage of the cross-linker upon UV excitation. CID-cleavable 
groups provide the possibility for cleaving the cross-links inside the mass spectrometer, in which 
case the intact cross-linked precursor ion can be isolated and fragmented.  
Reporter ions represent another CID-cleavable strategy for detecting cross-linked 
peptides by mass spectrometry. Specifically labeled chemical groups are incorporated into the 
structures of the cross-linkers, and these produce specific “reporter ions” under CID 
fragmentation conditions 
80
. However, low abundance cross-links may be missed during the LC-
MS/MS screen, and therefore affinity enrichment of cross-linked proteins or peptides may need to 
be employed for this approach to be successful.  
1.2.3.2 Affinity groups 
Placing an affinity group within the structure of the cross-linker reagent leads to 
enrichment of all cross-linker-containing species. Affinity cross-linker may contain a biotin group 
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that allows enrichment of cross-linker-containing species by avidin beads
81
 . A modular approach 
was developed for the synthesis of trifunctional cross-linking reagents
82
. A trifunctional cross-
linker sulfo-SBED has been used to map the interface regions between calmodulin and its target 
peptide. One drawback of sulfo-SBED is that the spacer arm is longer (23Å ) than preferred 
length of ~8 to 15 Å, which is considered to provide the most useful distance geometry 
information about the orientation of lysine residues for threading calculations
83
. Unfortunately, 
the affinity tag enriched cross-linker-containing peptides include an overwhelming quantity of 
dead-end cross-links.  
1.2.3.3 Isotopically-tagged cross-linkers 
Isotopically-tagged reagents are based upon substitution of one or more atoms in a cross-
linker with heavy stable isotopes, usually deuterium or 
13
C, which create heavy and light forms of 
the reagent that are chemically indistinguishable but whose presence is detectable in the mass 
spectra due to their mass difference from the natural isotopic abundance species. Following cross-
linking of intact proteins, proteolytic digestion, and separation of the resulting peptides, peptides 
cross-linked by a 50% isotopically tagged reagent can be distinguished in the mass spectra as 
doublet peaks with 1:1 ion signal ratio, and this allows the detection of low abundance cross-
linked species in MS. For example, the 12-deuterium labeled cross-linker provides a 12-Da mass 
shift between the light isotope and heavy isotope species. Only cross-linker modified peptides 
have these unique doublet peaks, and this enables them to be distinguished from the much more 
abundant unmodified common peptides (Figure 1-18). This feature enables us to employ targeted 
MS2 fragmentation strategies for analysis of the cross-linked peptides, such as inclusion list and 
mass tag methods. Furthermore, the isotope coding also facilitates interpretation of the MS2 
spectra. By comparing the MS2 spectrum of a cross-linked peptide with the light cross-linker to 
the MS2 spectrum the same cross-linked peptide containing the heavy cross-linker, we can easily 
45 
 
 
distinguish common fragment ions without cross-linkers from the fragment ions with cross-
linkers, because the ions containing the cross-link exhibit a 12-Da mass shift upon comparison of 
the MS2 spectra of the light and heavy precursor ions (Figure 1-17). 
 
Figure 1-17. Using isopotically-tagged cross-linkers for protein cross-linking studies. 
One advantage of of 
13
C-, 
15
N-, and 
18
O-labeled cross-linkers over deuterium-labeled 
cross-linkers is that the unlabeled and 
2
H12-labeled cross-linked species elute separately during 
reversed-phase chromatography (about 3-sec shift), which makes detection of the 1:1 ratio of the 
parent-ion doublet and the targeted MS/MS more challenging.   
Another alternative for isotope labeling is N-terminal modification (NTM), in which 
isotopically coded NTM reagents are used to label cross-linked peptide mixtures. Since inter-
peptide cross-links have two N-termini, they will incorporate two NTM groups versus the one 
modification to the free peptide, mono-linked peptides and intra- cross-linked peptides. This 
results in a specific isotopic signature of 1:2:1 intensity ratios for the inter-cross-linked peptides.  
However, the modification of ε-amino groups of lysine residues can potentially produce a false 
positive isotopic signature for lysine-containing free peptides, and for peptides with mono-links, 
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and intra-peptide cross-links. Blocking lysine by methylation prior to enzymatic digestion may 
solve this problem, but can result- in the generation of large trypic peptides due to the missed 
cleavage. Combining isotopically tagged cross-linking and NTM allows discrimination between 
the isotopic signatures of the free peptides and inter-peptides. However, this can also complicate 
the spectra. 
18
O-labelling is another form of isotope-labeling for detection of cross-linked peptides. 
The use of 
18
O-labeled water during proteolytic digestion incorporates a heavy oxygen atom into 
the digestion products. Because they contain two C-termini, the cross-linked inter-peptides 
incorporate twice the number of heavy oxygen atoms as do the free peptides, or peptides with 
mono-links, and or intra-peptide cross-links. However, incomplete incorporation of the second 
oxygen atom due to sequence-specific affinity and back-exchange reactions will produce 
complications. This can be addressed by optimizing the exchange reaction conditions, generally 
by using an elevated concentration of the enzyme and by complete removal/inactivation of the 
enzyme to in order to quench back-exchange reactions
84
. 
One drawback of the isotopic labeling is that the absolute signal intensities of the cross-
linked peptides are lowered because the signal is divided between the light and heavy forms of 
the reagents. This may be an issue for biological samples available in only limited amounts; this 
difficulty can be addressed by enrichment using affinity purification. Another complication is that, 
for high molecular weight cross-linked peptides that have broad natural isotopic distributions, , 
stable isotope labeling may not create a sufficient mass shift between the products of the light and 
heavy reagents, leading to overlapping of the peak distributions, and therefore complicating 
detection of cross-links. In such cases, a larger mass difference between light and heavy isotope 
forms should be used to address this issue.  
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1.3 Protein aggregate and aggresome formation 
Misfolding, damage, or mutation of proteins results in abnormal polypeptides
85
, which 
can be refolded or degraded by molecular chaperones or the ubiquitin-proteasome system (UPS) 
(Figure 1-18). However, under certain conditions, such as UPS impairment or increased oxidative 
stress, these abnormal proteins can accumulate in the cytoplasm to form small aggregates. These 
aggregates can cause cell toxicity leading to various pathologies, including major 
neurodegenerative disorders, such as Parkinson disease (PD), Alzheimer disease (AD), 
Huntington disease (HD), etc. To reduce toxicity, the cell machinery can couple these small 
aggregates to the dynein motor complex and retrograde transport them along microtubules to the 
centrosome, forming an organelle called an aggresome
86
 (Figure 1-18). 
Aggresome formation has been proposed as a protective cellular response to the 
accumulation of aggregating abnormal polypeptides when chaperones and the UPS fail to handle 
abnormal species
87
, e.g., in aging or disease. Indeed, a close correlation between aggresome 
formation and cell survival has been reported
88
. Aggresomes sequester misfolded proteins and 
recruit UPS components and chaperones to facilitate the clearance of the aggregated proteins. 
Aggresomes also facilitate elimination of protein aggregates by autophagy
89
. These events could 
have therapeutic implications for treatment of neurodegenerative diseases
87a
. 
The formation of the aggresome is a multi-step process. Aggregation of monomers occurs 
in the cell periphery, possibly by growth on an oligomeric seed. Small aggregates were observed 
to be delivered to the nascent inclusion body
90
. In this study, through use of immunofluorescence 
and transmission electron microscopy with immunogold labeling, either the overexpression of the 
mutant cystic fibrosis transmembrane conductance regulator (CFTRΔF508) or the inhibition of 
proteasome activity was shown to lead to the formation of an aggresome. The aggresome body 
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contained a detergent-insoluble, multi-ubiquitinated form of CFTR deposited at the centrosome, 
the microtubule organization center (MTOC). Disruption of microtubules blocked the formation 
of aggresomes. Similarly, inhibition of proteasome function has been reported to prevent 
degradation of unassembled presenilin-1 molecules, leading to their aggregation and deposition in 
aggresomes
90
. Aggresome formation was accompanied by a collapse of the intermediate filament 
(IF) cytoskeleton into a cage-like structure that encircled the aggresome. Aggresomes are 
composed of a core of aggregated proteins that are usually ubiquitinated, surrounded by 
intermediate filaments (such as vimentin), and enriched in chaperones (such as Hsp70, Hsp90 or 
TCP-1)
91
 and degradation components (such as 26S proteasomes and ubiquitin). This structure 
enlarges in response to inhibitors of proteasome activity, and additional pools of chaperones, 
ubiquitin, and proteasomal subcomplexes are recruited into the aggresome.  
Although several factors have been implicated in aggresome formation, the details of the 
molecular mechanisms governing each of these steps are largely unknown and represent clear 
targets for future investigation. Some questions that need to be addressed are: (a) How do small 
aggregates form and what therapeutic reagents can be used to prevent aggregation? (b) How do 
motors recognize and associate with the variable peripheral aggregates? (c) What are the 
signaling pathways responsible for chaperone and proteasome recruitment to the aggresome, and 
can they be amplified early to facilitate degradation of small aggregates? (d) What are the 
signaling pathways involved in IF rearrangements, and are changes in IF architecture relevant for 
pathogenesis? (e) What are the signaling pathways regulating autophagy, and can the process be 
selectively amplified for disposal of aggresomes? (f) What are the global transcriptional and 
translational changes that accompany aggresome formation, how do they affect cell function? 
Answers to these questions are likely to significantly enhance our ability to treat 
neurodegenerative diseases using mechanism-based therapeutic strategies.  Indeed, small 
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molecules that inhibit/promote aggresome formation have been investigated in order to better 
understand the mechanisms of inclusion formation and to be used as potential therapeutics for 
disease (reviewed in
87a
). For example, rapamycin, a compound that induces autophagy by 
inhibiting mTOR, reduced the levels of aggregated proteins and was found to be protective in 
both cell and animal models of neurodegenerative disease
92
. 
 
Figure 1-18. Pathways of cellular machinery for processing of abnormal polypeptides. 
1.4 Parkinson disease and Synphilin-1 
With continuous ageing of the population, a large group of neurodegenerative diseases 
(ND) characterized by late onset will increasingly enters the lives of many elderly. Many major 
ND, including Alzheimer disease (AD), Parkinson disease (PD), Amyotrophic Lateral Sclerosis 
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(ALS) and other hereditary diseases are characterized by deposit of abnormal polypeptides
93
. 
While having different causative agents, many ND have similar cellular and molecular 
mechanisms, and this similarity promises that insights and therapeutic approaches found for one 
of the ND may be employed in fighting the others.  
Parkinson disease (PD) was originally described by James Parkinson in 1817. PD is one 
of the most common neurodegenerative disorders and affects about 4 million people worldwide
94
. 
A hallmark of PD is the appearance of protein aggregates called Lewy bodies in affected 
dopaminergic neurons. Lewy bodies have many similarities with aggresomes and probably 
represent the same paradigm
95
 . The major component of Lewy bodies is α-synuclein96. 
Synphilin-1 associates with α-synuclein and is necessary for its targeting to Lewy body-like 
protein aggregates in cell culture
97
.  Recently, Zaarur et al.
98
 found that expression of Synphilin-1 
in HEK293 (human embryonic kidney) cells triggered formation of multiple small protein 
aggregates (Figure 1-19, left). Inhibition of proteasome activity by MG132 led to disappearance 
of multiple small aggregates and formation of a single large aggresome in the perinuclear region 
(Figure 1-19, middle). Moreover, formation of this aggresome was blocked by the microtubule 
poison nocodazole, resulting in accumulation of multiple aggregates (Figure 1-19, right). 
Immunostaining with an antibody against a centrosome component, γ-tubulin, demonstrated that 
this aggresome co-localized with the centrosome. These data clearly indicated that inhibition of 
the proteasome in leads to aggresome formation from small aggregates in Synphilin-1 expressed 
HEK293 cells. Thus, Synphilin-1 can be used as a model for study of aggresome formation. 
Synphilin-1 is a single 919-amino acid polypeptide composed of five domains: (NT) N-terminus 
(residues 1-348), ANK1 (Ankyrin-like repeat domain 1) (residues 348-504), CC (Coiled-Coil) 
(residues 505-560), ANK2 (residues 561-728), and (CT) C-terminus (729-919) (Figure 1-20). A 
series of deletion mutants of Synphilin-1 were constructed to investigate the functional domains 
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responsible for the aggresome formation process (Figure 1-20). Deletion of both the NT and CT 
did not change the aggregation response. In contrast, deletion of ANK1 still led to formation of 
small aggregates but not aggresome formation upon treatment with proteasome inhibitor whereas 
deletion of either the CC domain or the ANK2 domain prevented formation of small aggregates, 
indicating that ANK1 is aggresome-targeting and ANK2, together with the CC domain, 
constitutes the aggregation-promoting region of Synphilin-1. CC and ANK domains are common 
protein structural motifs and mediate protein-proteins interactions. Thus, we believe that both 
aggregate and aggresome formation in Synphilin-1 model require triggering signals by 
associating with other proteins. Indeed, Synphilin-1 forms dimers and interacts with α-synuclein 
via its central coiled-coil domain
99
. Synphilin-1 has been reported to bind to various proteins, 
including PARK2
86a, 91, 100
, SIAH1
100d, 101
, SNCA
97, 99, 100e, 100g, 102
, Ubiquitin
86a
, PIN1
102a
, UBC
100b, 
100d, 100g, 101b, 103
, PSMC4
104
, SIAH2
100d, 101a, 105
, GET4
106
, PTN
106
, SH2D3C
106
, AES
106
, AGXT
106
, 
C11of58
107
, CSNK2B
108
, GSK3B
105
, NUDT21
107
, PPP1CA
109
, HERPUD1
110
, PINK1
100e
, 
RNF19A
103c
, STUB1
111
, UBD
100f
, and YWHAB
105
.  Identification of Synphilin-1 associated 
proteins and their interacting domains would help to discern the cellular functions of Synphilin-1 
and the molecular mechanisms of formation of protein aggregates and aggresomes. Delineation of 
these processes should provide a better understanding of the pathogenesis of many protein 
misfolding disorders and advance the development of therapies for neurodegenerative diseases, 
including Parkinson disease.  
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Figure 1-19. Synphilin-1-GFP forms multiple aggregates in HEK293 cells and an aggresome 
upon treatment with the proteasome inhibitor. Fluorescent micrograph of cells transfected 
with Synphilin-1-GFP (Green fluorescent protein) plasmid (left), treated with MG132 (middle), 
and treated with MG132 and nocodazole (right). Adapted from Ref. (
98
). 
 
Figure 1-20. A scheme of the domains of Synphilin-1. Ankyrin-like repeat domain 1 (ANK1) is 
the aggresome-targeting domain. ANK2 and Coiled-coil domain (CC) are the aggregate-
promoting domains. 
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Chapter 2 : Optimization and application of chemical cross-linking for mass 
spectrometry 
2.1 Introduction 
The analysis of the three dimensional structure of a protein and the identification of its 
interaction partners are crucial to the study of the function of the protein. X-ray crystallography 
and nuclear magnetic resonance (NMR) spectroscopy determine a protein structure in high-
resolution, providing insights into stable interactions within a protein complex. These techniques 
require relatively large amounts (10 to 100 mg) of pure analyte in a particular solution or 
crystalline state, and take months to generate a molecular structure. Due largely to the 
development of soft ionization methods for large biomolecules, such as matrix-assisted laser 
desorption/ionization (MALDI)
2c
 and electrospray ionization (ESI)
112
, mass spectrometry (MS) 
plays a key role in proteomics, enabling the rapid and high sensitivity identification and 
characterization of proteins.  When biomolecules exceed the size accessible by NMR or afford 
inadequate crystallization, mass spectrometry, in combination with chemical cross-linking, can 
provide an alternative approach for characterization of protein structures and interactions by 
covalently connecting protein residues with bifunctional cross-linking reagents with certain 
distances measured on the Å scale. Identification of the cross-linked sites by tandem MS (MS/MS) 
draws conclusions based on the distance geometries of a protein complex, and thus provides 
valuable insights into protein interactions
113
. The obtained distance constraints can aid 
computational modeling of protein complexes for generation of low-resolution protein 
structures
114
.   
Chemical cross-linking followed by MS analysis has been employed in studies of protein 
structures
115
, protein-peptide
114a, 116
, protein-protein
80, 117
, protein-nucleic acid
118 
interactions using 
the bottom-up approach, in which the protein is reacted with a cross-linking reagent in solution, 
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followed by chromatographic separation, proteolytic digestion, and HPLC/MS analysis of the 
resulting peptides.  However, proteins or peptides can be lost or inadvertently chemically 
modified, e.g. due to posttranslational or other covalent modifications that may occur in 
chromatographic separation and proteolytic digestion steps, reducing sequence coverage, 
sensitivity and accuracy. In addition, these steps are offline and time-consuming, and are thus not 
suitable for high throughput and automation.  By taking advantage of various gas-phase 
fragmentation methods and the high resolving power of an advanced type of mass spectrometry, 
Fourier transform ion cyclotron resonance (FT-ICR) MS, McLafferty et al
 44, 119
 originally defined 
an alternative top-down approach, in which intact proteins are directly injected into the MS 
without proteolytic digestion and MS/MS methods are used to dissociate proteins and thus 
localize modifications. This approach eliminates proteolytic digestion, replacing it by gas-phase 
fragmentation and MS/MS analysis of the fragments to localize chemical modifications, allowing 
high throughput and automated identification of modified sites. This approach also eliminates the 
time consuming HPLC separation of digested peptides. Recently, Young et al 
120
 applied this top-
down approach to assign internally cross-linked residues of ubiquitin monomers, demonstrating 
that intramolecular cross-linking is able to provide distance constraints for studies of protein 
tertiary structure.    
While intramolecular cross-linking is primarily used for modeling the tertiary structure of 
proteins, intermolecular cross-linking studies focus on defining protein complex topology and 
protein-protein interactions. To this end, we developed a top-down MS approach and used it to 
analyze the intermolecular cross-linking of human hemoglobin, a tetramer consisting of two α 
and two β subunits. In this methodology, the cross-linked protein solutions were directly infused 
into the MS using a NanoESI source. The cross-linked protein complex ions were isolated and 
fragmented by various methods, such as Collision Induced Dissociation (CID), Higher-energy C-
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trap dissociation (HCD) or nozzle-skimmer dissociation (NSD).  The generated tandem MS 
spectra were used to localize the cross-linked residues. Both α-α and β-β intermolecular cross-
linking were found and the cross-linking sites on the protein were identified, obtaining distance 
constraints between subunits of human hemoglobin protein complex. The results are consistent 
with reported X-ray structural determinations. This methodology could become a valuable new 
approach to characterize protein complex and protein-protein interaction with high throughput 
and automation. 
2.1.1 Cross-linking reactions 
Unless specified, all chemical reagents were purchased from Fisher Scientific (Fair Lawn, 
NJ). All buffers were prepared with 18 mΩ∙cm Milli-Q water. Lyophilized human hemoglobin 
(Sigma-Aldrich, St. Louis, MO) (6.80 mg) was dissolved (20 μM) in 5 mM sodium acetate buffer 
(pH 7.5). Bis[sulfosuccinimidyl] suberate (BS³) powders (Pierce Chemical Co, Rockford, IL) 
were dissolved in 5 mM sodium acetate buffer (pH 7.5) to prepare 0.5 mM, 1 mM, 2.5 mM, 5 
mM and 10 mM BS
3
 solutions.  Six μl of each BS3 solution was added to a mixture of 294 μl of 
20 μM human hemoglobin and 300 μl of 5 mM sodium acetate buffer (pH 7.5).  One hundred μl 
of each reaction mixture was aliquoted into 20 μl of 20 mM ammonium acetate after 5, 15, 30, 60, 
and 120 min to quench the cross-linking reactions. The quenched solutions were incubated at 
room temperature for 15 min, and then frozen at -20 ºC prior to MS analysis. 
2.1.2 Top-down tandem MS of cross-linked human hemoglobin 
Samples were equilibrated with 5% Formic Acid (FA)/50% Acetonitrile (ACN)/50% 
Water (ESI spray buffer), and were directly infused into an LTQ-Orbitrap
TM
 MS (Thermo 
Scientific, Waltham, MA) using a TriVersa NanoMate ESI source (Advion, Ithaca, NY). Samples 
were ionized in the positive mode, with a voltage of 1.45 kV on the nanospray chip and a gas 
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pressure of 0.3 psi. The internal diameter of the chip nozzle was 2.5 µm; this provided a flow rate 
of 160 nl/min. The MS spectra were acquired manually to analyze the peaks of cross-linked 
hemoglobin dimers. The cross-linked hemoglobin dimers were isolated with an isolation window 
of 10 m/z and fragmented by CID at 15 eV. Tandem mass spectra were deconvoluted using the 
Xcalibur
TM
 software (Thermo Scientific, Waltham, MA).  Fragment mass lists were analyzed 
using BUPID-Topdown (Boston University Protein Identifier-Topdown), an in-house algorithm 
for top-down protein MS peak list analysis.  The protein crystal structure was processed by 
Protein Workshop
121
 (Version 4.0.1) and Coot
122
 (Version 0.7-pre-1). 
2.2 Results and discussion 
Bis(sulfosuccinimidyl)suberate (BS
3
) is a homobifunctional, water-soluble, non-cleavable 
and membrane impermeable cross-linker. It contains an amine-reactive N-hydroxysulfo-
succinimide (NHS) ester at each end of an 8-carbon spacer arm with a length of 11.4Å (Figure 2-
1). NHS esters react with primary amines at pH 7-9 to form stable amide bonds, along with 
release of the N-hydroxysulfosuccinimide group. Proteins, including antibodies, generally have 
several primary amines in the side chains of lysine (K) residues and the N-terminus of each 
polypeptide that are available as targets for NHS-ester cross-linking reagents. BS
3
 was chosen 
over its non-water soluble counterpart, dissucinimidyl suberate (DSS), because the hydrophilic 
sulfonyl moiety of BS
3
 makes it water soluble, and therefore easily able to access hydrophilic 
protein surfaces to perform intermolecular cross-linking. In other words, BS
3
 can react in 
physiologic solutions to preserve protein quaternary structures and protein-protein interactions 
under their favorable circumstances.  On the other hand, DSS is a less hydrophilic cross-linker, 
which can easily access internal hydrophobic residues of proteins for intramolecular cross-linking.  
If an NHS ester-based cross-linker molecule encounters a primary amino group on the protein, it 
can react to form an intermediate structure. This intermediate may hydrolyze to form a so-called 
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“mono-link” (Figure 2-1) (Δm = 156.0781Da), or it may react with another lysine in the same 
polypeptide chain to form a so-called “loop-link” (Figure 2-1) (Δm = 138.0675Da), or it may 
react with another lysine in another protein chain to form a “cross-link” (Figure 2-1) (Δm = 
138.0675Da). All unreacted NHS-esters were hydrolyzed or quenched with ammonium acetate 
stop solution. Top-down MS/MS fragmentation of intermolecular protein cross-linking can 
determine protein identity as well as cross-linking residues, and this provides useful information 
for studies of protein structures and protein-protein interactions. 
 
Figure 2-1. Protein cross-linking reactions with BS
3
. BS
3
 has two reactive ends and an 11-Å 
spacer arm, and therefore, only physically direct interaction partners can be cross-linked. A cross-
linker can react with interacting proteins to form three types of products, mono-linking, intra-
protein loop-linking, and inter-protein cross-linking. 
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Different cross-linker/protein ratios and reaction times were assessed to optimize the 
reaction conditions, in terms of the lowest amount of cross-linking reagent and reaction time, in 
order to preserve the native tertiary structure of the protein under analysis. Figure 2-2 shows the 
MS spectra of the cross-linking reaction mixture at the 5-min time point, at different cross-
linker/protein molar ratios. The intact protein signal decreased as the cross-linking concentration 
increased. The signal of modified protein species started to appear at the cross-linker/protein 
molar ratio of 2.5/1, and increased as the cross-linking concentration increased. Figure 2-3 shows 
the MS spectra of the cross-linking reaction mixture at the cross-linker/protein molar ratio of 
2.5/1 at different reaction times.  The cross-linker modified protein signal increased as reaction 
time increased. A very low abundance peak of the cross-linked protein signal was first detected in 
the MS spectra recorded at 120 min.
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Figure 2-2. MS spectra of the cross-linking reaction mixture at 5-minute reaction time at 
different cross-linker/protein molar ratios. The decrease of the intact protein signal and the 
appearance of modified species were observed as the cross-linker/protein molar ratio increased. 
 
Figure 2-3. MS spectra of cross-linking reaction mixture at cross-linker/protein molar ratio 
1:2.5 at different reaction times.  The presence of a very low abundance peak of the cross-
linked species was observed as the reaction time increased. 
Both cross-linked α-α Hemoglobin subunits (Figure 2-4) and cross-linked β-β 
Hemoglobin subunits (Figure 2-5) could be detected in the MS spectra obtained for the product 
mixture resulting from the cross-linking reaction.  No peaks corresponding to α-β cross-linking 
were found. The cross-linked ion species were isolated and fragmented by LTQ-CID and HCD in 
the C-trap or by nozzle-skimmer dissociation (NSD) on the LTQ-Orbitrap MS. Figure 2-6A 
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shows the MS/MS spectrum obtained for the [M+33H]
33+
 peak at m/z 921.9144 that was assigned 
to cross-linked α-α chains of hemoglobin. As shown in Figure 2-6B, the appearance of the 
complementary ion pair “α+b1” and “y140” indicates that the unambiguous cross-linked site on 
one α chain is Val1, the N-terminus of the α chain. The appearance of “α+y14” indicates that the 
corresponding cross-linked site is located after Phe128 in the second α chain, therefore the only 
possible cross-linking residue is Lys139 on the second α chain (Figure 2-6B). This result is 
consistent with the published X-ray structure of human hemoglobin, in which the through-space 
distance between Val1 (Chain A) and Lys139 (Chain C) is 8 Å (PDB code: 1XXT
123
) (Figure 2-
7). Figure 2-8A shows the MS/MS spectrum of the [M+22H]
22+
 peak at m/z 1463.8582 that was 
assigned to “cross-linked β-β chains plus two BS3 mono-linkers”. In this spectrum, no b ion 
higher than b79 (i.e, up to Asp79) was found, and no y ion higher than y63 (i.e, up to Thr84) was 
found, meaning that both cross-linking sites must be located between Asp79 and Thr84 in the 
sequence of the β chain. The only possible cross-linking residue in this sequence range that can 
react with BS
3
 is Lys82 (Figure 2-8B). Thus, the unambiguous cross-linking pair is Lys82-Lys82 
on the two β chains. This result is also consistent with the published X-ray structure hemoglobin, 
in which the distance between Lys82 (Chain B) and Lys82 (Chain D) is 8.5 Å (PDB code: 
1XXT
123
) (Figure 2-9).  
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Figure 2-4. MS spectrum of cross-linked α-α hemoglobin chains.  The cross-linked product 
from two α hemoglobin chains (m/z 921.9144, z = 33) was found in the cross-linking reaction 
mixture at 5 minutes reaction time at cross-linker/protein molar ratio 5:1. 
 
Figure 2-5. MS spectrum of cross-linked β-β chains with two mono-linkers. The cross-linked 
product from two β hemoglobin chains (m/z 1463.8582, z = 22) was found in the cross-linking 
reaction mixture at 30 minutes reaction time at cross-linker/protein molar ratio 5:1. 
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Figure 2-6. MS2 spectrum of cross-linked hemoglobin α-α chains. (A) CID MS/MS spectrum 
of m/z 921.9144, assigned as the [M + 33H] 33+ of cross-linked hemoglobin α-α subunits. (B) 
Product ion assignments for tandem MS of cross-linked Hemoglobin α-α subunits. 
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Figure 2-7. Distance between cross-linking sites on α-α cross-linked subunits. The α-α cross-
linking result is consistent with the published X-ray structure of human hemoglobin, in which the 
through-space distance between Val1 (Chain A) and Lys139 (Chain C) is11.3 Å (PDB code: 
1XXT
123
). The figure was modified from the X-ray structure in Ref [
123
]. 
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Figure 2-8. MS2 spectrum of cross-linked hemoglobin β-β chains. (A) CID MS/MS spectrum 
of m/z 1463.8582, assigned to the [M + 22H]
22+
 of cross-linked hemoglobin β-β subunits with two 
BS
3
 mono-linkers. (B) Product ion assignments for tandem MS of cross-linked Hemoglobin β-β 
subunits. 
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Figure 2-9. Distance between cross-linking sites on β-β cross-linked subunits. The β-β cross-
linking result  is consistent with the published X-ray structure hemoglobin, in which the space 
distance between Lys82 (Chain B) and Lys82 (Chain D) is 11.0 Å (PDB code: 1XXT
123
). The 
figure was modified from the X-ray structure in Ref [
123
].  
 This methodology is currently being applied to studies of conformational changes of wild 
type Transthyretin (TTR) and variant forms that result from gene mutations. These changes are 
associated with TTR amyloidosis. Since TTR monomers persist as the most abundant species in 
cross-linking reaction mixtures, and therefore the MS signals of the cross-linked TTR dimers 
have relatively low abundances, we have found that prefractionation of cross-linked proteins prior 
to MS analysis is necessary.   
2.3 Conclusions 
This work demonstrates that top-down mass spectrometry, in combination with chemical 
cross-linking, can be used to obtain intermolecular distance constraints in a protein complex, and 
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can therefore provide structural information complementary to X-ray crystallography and NMR 
for studies of protein-protein interactions. The top-down approach is much more amenable to 
automation and high throughput since it eliminates the need for time-consuming chromatographic 
separations and in-gel digestions required by the Bottom-Up approach. The use of multiple ion 
isolation methods, followed by various dissociation methods such as CID, HCD and NSD 
improved the sensitivity of the technique. Other ion fragmentation methods such as ECD and 
IRMPD should also be investigated to obtain more structural information, since they may provide 
more extensive fragmentation.  MS
3
 experiments could be employed to further explore cross-
linking sites that remain ambiguous after the initial MS/MS analysis. Investigation of a wider 
range of cross-linking reagents with different length and hydrophilicity could also provide further 
structural information.  Future applications of this methodology to studies of protein aggregation 
will include study the aggregation processes involved in amyloid disease. Characterization of 
protein interactions associated with aggregation and aggresome formation using this approach 
should be able to provide valuable insights into the cellular mechanisms of protein aggregation 
and neuronal death. 
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Chapter 3 : Determination of Synphilin-1 protein interaction networks using tandem 
affinity purification and mass spectrometry 
3.1 Introduction 
Molecular chaperones and the ubiquitin-proteasome system (UPS) play an important role 
in handling soluble abnormal polypeptides that result from misfolding, damage, or mutation
85
. 
Under certain conditions, such as UPS impairment or increased oxidative stress, these systems 
fail to adequately refold or degrade abnormal proteins, which then accumulate in the cytoplasm to 
form small aggregates. These aggregates can cause cell toxicity leading to various pathologies, 
including major neurodegenerative disorders 
93
, such as Parkinson disease (PD), Alzheimer 
disease (AD) and Huntington disease (HD). To reduce toxicity, the cell machinery couples these 
small aggregates to the dynein motor complex and retrograde transports them along microtubules 
to the centrosome, forming an organelle called an aggresome
86
. Aggresomes sequester misfolded 
proteins and are actively involved in refolding and proteasomal or autophagic degradation 
89
. 
Aggresome formation has been proposed as a protective cellular response to the accumulation of 
aggregating abnormal polypeptides when chaperones and the UPS fail to handle abnormal 
species
87
, e.g. in aging or disease. Indeed, a close correlation between aggresome formation and 
cell survival has been reported 
88
. There is a strong similarity between aggresomes and cellular 
inclusions associated with various “protein conformation” diseases, e.g. Lewy bodies in the 
brains of Parkinson disease patients. The major component of Lewy bodies is α-synuclein96. 
Synphilin-1 associates with α-synuclein, is necessary for its targeting to Lewy body-like protein 
aggregates in cell culture
97
 and has been implicated in the pathogenesis of Parkinson disease. 
Expression of Synphilin-1 in mammalian cells triggers formation of protein aggregates which are 
transported to form aggresomes upon proteasome inhibition
98
. Two adjacent protein binding 
domains of Synphilin-1 are individually critical for formation of aggregates and aggresomes, 
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respectively
98
, indicating that Synphilin-1 associated proteins are involved in regulation of 
aggregate and aggresome formation. Identification of Synphilin-1 associated proteins and 
determination of their propensity for change in response to proteasome inhibition would help to 
discern the molecular mechanisms of formation of protein aggregates and aggresomes. 
Delineation of these processes should provide a better understanding of the pathogenesis of many 
protein misfolding disorders and advance the development of therapies for neurodegenerative 
diseases, including Parkinson disease. 
Several methods have been employed for determining protein-protein interactions, 
including the yeast two-hybrid system, co-immunoprecipitation, and pull-down assays. Affinity 
purification coupled with quantitative mass spectrometry has become the primary method for 
studying in vivo protein interactions of protein complexes and whole organism proteomes
124
. 
Tandem affinity purification (TAP) can reduce nonspecific binding to more reliably determine 
protein-protein interactions
125
. However, the increasing sensitivity of MS makes it impossible to 
completely avoid the detection of impurities. Label-free quantitative mass spectrometry based on 
precursor ion signal intensities has been used to distinguish specific from nonspecific interactions 
and thus obtain higher confidence
126
.  
Here we used tandem affinity purification in combination with label-free quantitative 
mass spectrometry to map Synphilin-1 interaction networks. Fifty-seven proteins significantly 
associated with Synphilin-1 were identified and have been subjected to functional and pathway 
analysis, which revealed that these proteins are mainly involved in protein and RNA metabolism.  
Surprisingly, the protein associations showed no significant change upon proteasome inhibition. 
This may be triggering the formation of aggresome is due to transient or weak interactions, which 
may not retain in the tandem affinity purification. 
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3.2 Experimental procedures 
3.2.1 Chemicals and antibodies 
All chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) 
unless mentioned otherwise.  
The antibody against GFP was from Clontech (Palo Alto, CA, USA), and the antibodies 
against, α-tubulin, and actin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
3.2.2 Constructs, cells cultures, transfection, and treatments 
For tandem affinity purification, we employed the pEGFPN1 plasmid with cloned 
depletion #6 of human Synphilin-1 (from amino acid residue 349 to 729) with a His-tag at the N-
terminus and a GFP-tag at the C- terminus, as described previously
98
. For knockdown of CK2, the 
retroviral expression construct with C-terminally GFP tagged Synphilin-1 (Syn-GFP) and N-
terminally RFP tagged Ubiquitin (mRFP-Ub) subcloned into pCXbsr vector was used as reported 
earlier
98
.  
HEK293T (human embryonic kidney) or HeLa cells were grown in Dulbecco’s modified 
Eagle’s medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine 
serum (FBS) at 37 °C in an atmosphere of 5% CO2. Cells were transfected using Lipofectamine 
2000 reagent (Life Technologies, Carlsbad, CA, USA) with empty vector (later designated as 
“Control” or “V”) and depletion 6 of Synphilin-1 (later designated as “Syn” or “S”), according to 
the manufacturer’s instructions. For proteasome inhibition, at 48 h after transfection, cells were 
incubated with 5 µM of MG132 (Biomol, Plymouth Meeting, PA) for 4 h (later designated as 
“Syn+MG” or “M”). Cells were harvested and stored at -20 ˚C until lysis. Four biological 
replicates were prepared for each sample. For analysis with a fluorescence microscope, cells were 
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grown on Lab-Tek
TM
 chambered coverglass (NUNC, Rochester, NY, USA) pretreated with poly-
L-lysine. 
3.2.3 Cell lysis and tandem affinity purification 
All the following procedures were performed at 4 °C. Cells were lysed with lysis buffer 
composed of 6xHis wash buffer (BD Bioscience, San Jose, CA, USA), supplemented with 1% 
Triton X-100, 20 mM imidazole, 10 mM NaF, 10 mM β-glycerophosphate, 10 mM sodium 
orthovanadate, 1 mM PMSF, His-protease inhibitor cocktails, and Tyrosine/alkaline phosphatase 
inhibitor cocktails. Samples were adjusted to have equal concentrations of total protein. 
Protein extracts from six 15-cm
2
 tissue cell culture dishes with 90% confluence of each 
sample were incubated with 50 µl of HisPur cobalt resin (Pierce, Rockford, IL, USA) for 30 min 
with rotation. Samples were passed through the same cobalt resin three times and washed with 
lysis buffer. Samples were eluted with 6xHis elution buffer (BD Bioscience, San Jose, CA, USA) 
supplemented with 300 mM imidazole. Eluates were diluted with anti-GFP wash buffer (40 mM 
Tris-HCl, pH 7.4, 150 mM NaCl) and incubated with 50 µl of agarose conjugated Anti-GFP 
beads (MBL, Woburn, MA, USA) for 45 min with rotation. Samples were passed through the 
same anti-GFP beads three times and washed with anti-GFP wash buffer. Samples were eluted 
with 80 µl of 8 M urea supplemented with 40 mM Tris-HCl, pH 7.4, 150 mM NaCl. Samples 
were stored at -80 °C before trypsin digestion. 
3.2.4 Immunoblot analysis 
Proteins were mixed with equal volume of 2-fold Laemmli sample buffer (Bio-Rad, 
Hercules, CA, USA) and 5 % (v/v) 2-mercaptoethanol and boiled for 10 min at 95 °C. Proteins 
were subsequently separated by a 4-12% NuPAGE gel (Life Technologies, Grand Island, NY, 
USA) and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). Membranes 
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were blocked for 30 min in blocking solution (5% milk in 1xTris buffered saline, 20 mM Tris-
HCl, pH 7.4, 150 mM NaCl, and 0.1% Tween-20) at room temperature and incubated with 
respective primary antibody overnight at 4 °C, and then incubated with horseradish peroxidase-
conjugated secondary antibodies (Cell Signaling, Danvers, MA, USA), and proteins were 
visualized using ECL reagents (Thermo Fisher Scientific, Rockford, IL, USA). 
3.2.5 Trypsin digestion 
Samples were reduced with 50 mM dithiothreitol (DTT) for 1 h at room temperature, and 
alkylated with 100 mM iodoacetamide for 30 min in the dark at room temperature. Alkylation 
was quenched with 100 mM DTT. The proteins were digested with trypsin (Promega, Madison, 
MI, USA) (1:50 (w/w), trypsin: protein) and samples were incubated at 37 °C for 16 h. Digestion 
were quenched by 5% formic acid and desalted with C18 RP Macro spin columns (The Nest 
Group, Southborough, MA, USA) using the manufacturer’s instructions. Peptides mixtures were 
evaporated to dryness using a Speed Vac™ (Thermo Fisher Scientific, Waltham, MA, USA) and 
stored at -80 °C until LC-MS/MS analysis. 
3.2.6 Reversed phase liquid chromatography and mass spectrometry 
LC-MS/MS analysis was performed on a nanoACQUITY UPLC (Waters, Milford, MA, 
USA) online coupled to a Q-Exactive mass spectrometer (Thermo Scientific, San Jose, CA, USA) 
with a TriVersa NanoMate (Advion, Ithaca, NY, USA) chip-based electrospray ionization source. 
Samples were suspended in 1% acetonitrile, 0.1% formic acid in HPLC-grade water and loaded to 
the UPLC system. The peptides were first trapped on a 180 µm x 20 mm, 5 µm particle size 
Symmetry@C18 trapping column (Waters, Milford, MA, USA) at a flow rate of 15 µl/min with 
98% buffer A (1% acetonitrile, 0.1% formic acid in HPLC-grade water) and 2% buffer B (99% 
acetonitrile, 0.1% formic acid in HPLC-grade water) for 1 min, and then separated on an 150 µm 
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x 100 mm, 1.7 µm particle size BEH130 C18  analytical column (Waters, Milford, MA, USA) by 
a gradient from 2% - 50% of buffer B at 500 nL/min flow rate for 65 min and wash at 80% for 6 
min. The eluting peptides were analyzed by the Q-Exactive using Full MS/data dependent (dd)-
MS
2
 (TopN) mode. From the high resolution MS scan, the top ten most abundant peptide ions 
were selected for fragment analysis if they exceeded an intensity of 8.3e4. Singly charged 
peptides were excluded from fragment analysis. The normalized collision energy for high energy 
collision-induced dissociation (HCD) was set to a value of 30eV with an isolation width of 3 u. 
Every ion selected for fragmentation was excluded for the next five sec by dynamic exclusion. 
3.2.7 Label-free quantification 
The acquired spectra (Thermo .raw files) were imported to the Progenesis LC-MS 
software (version 4.04441.29989, Nonlinear, Durham, NC, USA) for label free quantification. 
Profile data of the MS scans were transformed to peak lists with Progenesis LC-MS using a 
proprietary algorithm. After selecting one LC-MS/MS run as a reference, the retention times of 
all other runs within the experiment were aligned by automatic alignment of all retention times to 
maximal overlay of the 2D feature maps. Features detection was performed using the default 
automatic sensitivity method. After alignment, normalized quantitative abundance ratios were 
calculated over all features in all runs. No feature was excluded for subsequent analysis so that 
abundance data used for relative quantification was obtained for every peptide ion in every run to 
assure that the data variance was representative of the full dataset. The biological replicates of 
each sample were then grouped: Control, Syn, and Syn+MG, and statistical analyses were 
performed using normalized abundances for one-way analysis of variance (ANOVA) calculations 
of all detected features. All detected features were included for peptide statistics and 
identification. All features with MS/MS fragmentation information were exported as a Mascot 
generic format file (mgf) for peptide identification using Mascot (see database search and protein 
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identification section below). Peptide identification results from Mascot were imported back to 
Progenesis LC-MS.  Identified peptides (with Mascot ion score ≥ 20 and mass error ≤ 5 ppm) of 
an identified protein were included and the total cumulative abundance was calculated by 
summing the abundances of all peptides assigned to the respective protein. For peptides that 
matched to multiple proteins, protein grouping was performed. However, all features that were 
identified as part of protein were used for respective protein quantification. Calculations of the 
protein p value (one-way ANOVA) were then performed on the sum of the normalized 
abundances across all runs. Only proteins with two or more identified peptides and at least one 
unique peptide were included for further analyses. Proteins with ANOVA value of p < 0.05 and 
net changes of > 2-fold across two samples were regarded as significantly enriched for all further 
bioinformatics analysis. 
3.2.8 Database search and protein identification 
MS/MS data were searched against Uniprot/Swissprot 57.15 (Release 2011_10, 
Taxonomy, Homo sapiens; protein entries, 20,266) for peptide identification using Mascot 
(version 2.3.2) (Matrix Science Ltd.). The following search parameters were used: enzyme, 
trypsin; two missed cleavages allowed; fixed modification, carbamidomethyl (C); variable 
modifications, oxidation (M); peptide mass tolerance, 5 ppm; fragment ion mass tolerance, 0.5 Da. 
A Mascot-integrated decoy database search calculated a false discovery rate of 0.69%. Peptides 
with ion scores of 20 above and significance threshold p value < 0.05 from Mascot were deemed 
correct identification and imported to Progenesis LC-MS. After solving conflicts of peptide 
identification, protein and peptide identifications from Progenesis LC-MS are listed in Excel for 
further analysis. 
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3.2.9 GO enrichment, pathway, and network analysis 
Significantly associated proteins observed from differential analysis using Progenesis 
LC-MS (p < 0.05, fold change > 2, and ≥ 2 peptides assigned) were analyzed. Classification and 
functional enrichment analysis of the identified proteins were performed using Database for 
Annotation, Visualization and Integrated Discovery™ (DAVID)127 for the biological process 
(BP), molecular function (MF), and cellular component (CC). In order to make the functional 
categories more understandable, terms were clustered according to their functional similarity 
using Reduce and Visualize Gene Ontology™ (REViGO)128. REViGO parameter settings are 
listed as follows: “allowed similarity” was set as “small (0.5)”; “p-values” were associated to GO 
categories, p-values; “Homo sapiens” was selected as database with GO term; “SimRel” was 
selected as semantic similarity measure to be used.”. Significantly regulated proteins were 
imported to Ingenuity Pathway Analysis™ (IPA) (Ingenuity Systems, Redwood City, CA, USA) 
to perform core analysis settings for their functional significance and in the context of biological 
association networks. The core analysis settings of 57 significantly associated proteins are listed 
as follows: Population of gene to consider for p-value calculations, Ingenuity Knowledge Base 
(Genes Only); Relationships to consider, Direct and Indirect Relationships; Network Generation, 
On; Data Source, All Selected; Confidence, Experimentally Observed; Species, All (Mammal & 
Uncategorized) with a stringent filter that filters molecules and relationships; Tissues and Cell 
Lines, the stringent filters for molecules and relationships were not applied; Mutation, All 
(mutant and wild type); Set Cutoffs, Focus on unregulated. 
3.3 Results 
3.3.1 Expression of Synphilin-1 and tandem affinity purification 
The experimental strategy (Figure 3-1A) was designed to identify Synphilin-1 interacting 
proteins and their quantitative changes upon proteasome inhibition using tandem affinity 
75 
 
 
purification and label-free mass spectrometry quantitation. We used a minimal deletion of 
Synphilin-1 (Figure 3-1B, later refer as “Syn”) that retains the ability to form aggresomes upon 
proteasome inhibition
98
.  Using this deletion construct, while retaining association with 
aggresome mediators, reduces the number of Synphilin-1 interacting proteins that are unrelated to 
aggresome formation. To determine the differential association of Synphilin-1 interactors in the 
process of aggresome formation, Synphilin-1 transfected cells were treated with a proteasome 
inhibitor, MG132, for 4 h before cell harvest (later  designated as “Syn+MG”).  After 4-h MG132 
incubation, “Syn+MG” formed aggresomes (Figure 3-1C, right panel) while “Syn” formed small 
protein aggregates, but no aggresome was observed (Figure 3-1C, left panel). As a negative 
control, empty vector transfected cells were prepared, and the same experimental procedure was 
followed (later designated as “Control”). Each experiment was performed in four biological 
replicates to enable statistical analysis within and across samples. 
Tandem affinity purification (TAP) can efficiently reduce non-specific proteins results 
from single step affinity purification to yield more accurate protein-protein interaction profiles
125
. 
To utilize this approach, Synphilin-1 was constructed with a His-tag at the N terminus so that it 
would be enriched by cobalt beads; and a GFP-tag at the C terminus so that it would be enriched 
by anti-GFP beads. In the first step, the His-tag/cobalt purification recovered Synphilin-1 with 60% 
efficiency, while the second step GFP/anti-GFP purification recovered 50% of synphililn-1, based 
on the Western blot intensity measured by ImageJ (Figure 3-1D). Overall, with this two-step 
purification, we achieved a 30% recovery rate for Synphilin-1, whereas the total protein quantity 
decreased 2000-fold (measured by BCA assay) after the two-step purification. Thus, we estimate 
that our tandem affinity purification effected a 600-fold purification.   
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Figure 3-1. Experimental strategy for the identification of Synphilin-1 interactome.  A, 
Experimental work flow. Synphilin 1 was constructed with a His-tag at the N-terminus and a 
GFP-tag at the C-terminus and was transfected into HEK293T cells. Cells were either treated 
with MG132 (right branch, Syn+MG) or remained untreated (middle branch, Syn). Empty vector 
transfected HEK293T cells were grown as a negative control (left branch, control). Following cell 
lysis, the Synphilin-1 components in protein extracts were recovered by first using cobalt beads, 
then using anti-GFP beads. Following trypsin digestion, the purified samples were analyzed by 
LC-MS/MS to identify and quantify the proteins. Each experiment was performed in four 
biological replicates. Functional enrichment analysis and pathway analysis were performed on 
significantly regulated proteins. B. Construct of Synphilin-1 deletion 6 (Del6). Ankyrin-like 
repeat domain 1 (ANK1) is the aggresome-targeting signal region. ANK2 and the coiled-coil 
domain (CC) together constitute the aggregation-promoting region. Del6 was constructed with a 
His-tag at the N terminus to enable trapping by cobalt beads and a GFP-tag at the C terminus to 
cause capture by anti-GFP beads. C. Expression of syphilin-1 resulted in formation of small 
protein aggregates (left panel) while proteasome inhibition by MG 132 led to formation of 
aggresomes (right panel). D. Tandem affinity purification efficiency. Cobalt beads eluate and α-
GFP beads flow-through fractions were reloaded five times after passage of the total lysate. The 
eluate from the α-GFP beads was reloaded ten times after passage of the total lysis. The first step, 
His-tag/cobalt purification, had 60% Synphilin-1 recovery, while the second step, GFP/anti-GFP 
purification, had 50% recovery of Synphilin-1, as measured by ImageJ. This two-step purification 
achieved an overall Synphilin-1 recovery rate of 30%. Since the total protein quantity decreased 
2000-fold after the two-step purification, our tandem affinity purification exhibited 600-fold 
purification efficiency.   
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3.3.2 Identification and quantitation of Synphilin-1 interactors 
Collectively, 115 proteins were identified in three samples (“Control”, “Syn”, and 
“Syn+MG”) at a false discovery rate of 0.69%. Only proteins with at least two identified peptides 
(including at least one unique peptide), were subjected to all subsequent data and bioinformatics 
analysis. Four biological replicates showed high reproducibility (Figure 3-2A). Using Progenesis 
LC-MS, a label free quantification software based on ion peak intensity, we detected 52,156 
features in Syn versus Control samples, including 42,338 features with fold change > 2; 18,734 
features with Anova p-value < 0.05 and fold change > 2.  In total, 6980 features generated 
MS/MS data yielding 63,728 MS/MS were exported to Mascot. Of these, 21,367 were identified 
and 1339 peptide identifications were imported back to Progenesis LC-MS. After peptide 
assignment conflicts were resolved, 1226 identified peptides remained and 157 proteins were 
identified, including 108 proteins with at least two identified peptides. We identified fifty-seven 
proteins which were significantly enriched in Synphilin-1samples (Figure 3-2B, shown in red 
squares, p < 0.05 and fold change > 2 in comparison to “control”). For Syn+MG versus Syn, we 
detected 32,253 features, including 10,652 features with fold change > 2;  871 features with 
Anova p-value < 0.05 and fold change > 2.  In total, 6035 features generated MS/MS data 
yielding 125,455 MS/MS which were exported to Mascot. Of these, 27,471 were identified and 
1160 peptide identifications were imported back to Progenesis LC-MS. After resolving peptide 
assignment conflicts, 1063 identified peptides remained and 154 proteins were identified, 
including 104 proteins with at least two identified peptides. The set of enriched proteins was not 
significantly changed upon proteasome inhibition (Figure 3-2C), indicating the MG 132 treatment 
did not change the association of proteins with Synphilin-1. Only significantly enriched proteins 
(p < 0.05 and fold change > 2) were used for subsequent bioinformatics analysis.  
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Figure 3-2. Quantitative analysis of protein expression in Synphilin-1 complex. A, Protein 
quantification between Syn and Control (p-value < 0.005). Four biological replicates of each 
sample showed high reproducibility. B and C, Volcano plots summarizing the protein 
quantification results in terms of the magnitude (log2 fold change) and significance (log10 p-
values) between Syn and Control (B) and between Syn+MG and Syn (C). Red line indicates the 
p-value < 0.05. Black lines indicate fold change > 2. Only proteins having at least two identified 
peptides (including one unique peptide) were included for all subsequent data analysis and 
bioinformatics analysis. Significantly enriched proteins (p-values < 0.05, fold change > 2) were 
selected for bioinformatics analyses.  
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3.3.3 Functional enrichment analysis of Synphilin-1 associated proteins 
In addition to identifying proteins that have significant differential changes in Synphilin-
1 pull-down, we sought to obtain biological insight from identified Synphilin-1 associated 
proteins by grouping significantly enriched proteins according to their gene ontology (GO) 
annotations using DAVID. The output GO terms were clustered according to their functional 
similarity using REViGO to make the functional categories more understandable. GO analysis 
revealed that significantly enriched proteins associated with Synphilin-1 span a range of 
biological processes and molecular functions (Figure 3-3).  
We classified significantly enriched proteins based on their involvement in biological 
processes. The most significant biological process represented by the Synphilin-1 associated 
proteins (Figure 3-3A) was protein polymerization. Other biological processes include translation, 
RNA splicing, RNA processing, and RNA metabolic process. The protein polymerization term 
includes tubulin complex components. The translation term contains ribosome components and 
translation elongation factor 1A-1 (EF1A1). The RNA metabolic process term mainly contains 
RNA splicing factors, like heterogeneous nuclear ribonucleoproteins (hnRNPs), DEAH box 
polypeptide 15 (DHX15), cleavage and polyadenylation specific factor 7 (CPSF7), RNA binding 
motif protein 15B (RB15B), and splicing factor 3B (SF3B2). 
We classified significantly enriched proteins based on their molecular function. The most 
significant molecular functions of Synphilin-1 enriched proteins (Figure 3-3B) were involved 
binding, including unfolded protein binding, chromatin binding, and RNA binding. The unfolded 
protein binding category includes heat shock protein family members, such as heat shock 70kDa, 
heat shock 60kDa, and others such as nucleophosmin 1(NPM). Another major term in the 
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molecular function category was structural molecule activity, which includes tubulin complex 
components and structural constituents of ribosome.  
Taken together, GO term enrichment results indicate the involvement of the Synphilin-1 
complex in the control of RNA and protein metabolism to handle misfolding proteins, and 
therefore the regulation of aggregate/aggresome formation. 
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Figure 3-3. Gene Ontology (GO) term enrichment analysis of significantly regulated 
proteins (p-values <0.05, fold change >2) in Synphilin-1 complex for (A) biological process 
and (B) molecular function. 
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3.3.4 Ingenuity pathway analysis of Synphilin-1 associated proteins 
To determine canonical pathways involved in Synphilin-1 associated proteins, Ingenuity 
pathway analysis was performed on the 57 proteins significantly enriched in Synphilin-1 samples 
(Table 3-1). The analysis revealed that Synphilin-1 associated proteins have impacts on multiple 
pathways (Figure 3-4A), such as germ cell-Sertoli cell junction signaling, gap junction signaling 
and 14-3-3-mediated signaling. The presence of tubulins in Synphilin-1 enriched proteins leads to 
IPA outcomes for these significant signaling pathways since tubulins have been reported to be 
involved in these pathways. Protein ubiquitination pathway is another significant pathway that 
may involve Synphilin-1 enriched proteins, as determined by IPA, due to the presence of heat 
shock proteins (mainly HSP70s). The protein ubiquitination pathway is correlated to the 
formation of aggregates and aggresomes, because the protein ubiquitination pathway regulates 
protein degradation and the dysfunction of this pathway leads to aggregate/aggresome formation. 
Ingenuity network analysis was also used to reveal binding and regulation maps of 
Synphilin-1 associated proteins. The top-three regulated networks are 1) RNA post-
transcriptional modification, protein synthesis, and cell morphology, 2) cancer, hematological 
disease, endocrine system disorders, and 3) cellular development, skeletal and muscular system 
development and function, and cell-to-cell signaling and interactions (Figure 3-5, Figure 3-6, 
Figure 3-7). To simplify the networks extracted from IPA analysis, we grouped proteins based on 
Figure 3-6 into corresponding protein complexes, as highlighted in Figure 3-4B. In this network, 
proteins either directly interacted with (Figure 3-4B, red solid lines) or are regulated by (Figure 3-
4B, blue dash lines) one another. Most of these proteins and their interactions have been 
implicated in aggresome formation. Of particular interest, we observed that casein kinase 2 (CK2) 
is one of the central nodes in this protein interaction network. CK2 has been reported to 
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phosphorylate Synphilin-1 and reduces cytoplasmic inclusions
108
. This result inspired us to 
further investigate the role of CK2 in aggresome formation. 
Table 3-1. Proteins that significantly enriched with Synphilin-1. A list of proteins pull-
downed with synpihilin-1 by tanden affinity purification, identified by LC-MS/MS, and shown 
significantly enriched in “Syn” in comparison to “control” using quantification.The list was 
generated based on Progenesis LCMS quantification results of “Syn” as ANOVA p value < 0.05 
and fold change > 2 in comparison to “control”. Only the proteins presented in this table were 
used for subsequent bioinformatics analysis. 
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Figure 3-4. Ingenuity Pathway Analysis (IPA) of significantly regulated proteins. A. Top 
canonical pathways that are significantly represented by regulated proteins in the Synphilin-1 
complex using Ingenuity Pathway Analysis (IPA). B. Simplified binary protein-protein 
interaction map of the Synphilin-1 complex adopted from IPA network analysis. Red/pink 
colored nodes indicate up-regulation. Color intensities indicate the magnitude of regulation. Red 
solid lines represent direct interactions. Blue dashed lines represent indirect interactions.  
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Figure 3-5. The first-rated regulated networks of IPA analysis: RNA post-transcriptional 
modification, protein synthesis, and cell morphology. Red/pink colored nodes indicate up-
regulation. Color intensities indicate the magnitude of regulation. Solid lines represent direct 
interactions. Dashed lines represent indirect interactions. 
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Figure 3-6. The second-rated regulated networks of IPA analysis: cancer, hematological 
disease, endocrine system disorders. Red/pink colored nodes indicate up-regulation. Color 
intensities indicate the magnitude of regulation. Solid lines represent direct interactions. Dashed 
lines represent indirect interactions. 
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Figure 3-7. The third-rated regulated networks of IPA analysis: cellular development, 
skeletal and muscular system development and function, and cell-to-cell signaling and 
interactions. Red/pink colored nodes indicate up-regulation. Color intensities indicate the 
magnitude of regulation. Solid lines represent direct interactions. Dashed lines represent indirect 
interactions. 
3.4 Discussion 
We investigated Synphilin-1 interactors using tandem affinity purification and label-free 
quantitative mass spectrometry. The high expression efficiency of Synphilin-1and the facile 
formation of Synphilin-1 aggresomes in HEK293T cells
98
 make HEK293T an ideal model system 
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for studies of Synphilin-1 interactors. Tandem affinity purification largely eliminates non-specific 
contaminations by two sequential purifications. Use of the TAP approach resulted in 600-fold 
enrichment of Synphilin-1 in our protein extracts and enabled the detection of more than one 
hundred interacting proteins, indicating that our protocol retains specific Synphilin-1 interactors 
with high purification efficiency. It is interesting that there were no significant changes in the 
pattern of Synphilin-1 associated proteins following proteasome inhibition (Figure 3-2D). This 
observation may have two explanations. Firstly, the profile of associations could change in 
insoluble Synphilin-1 aggregates and aggresomes, which were not pulled down using affinity 
purification approaches and, if so, these changes would not be detected. Secondly, the triggering 
of aggresome formation may depend on transient or weak interactions, which may not be retained 
throughout the full course of tandem affinity purification.  
We used Progenesis LC-MS to achieve label-free quantification that is based on the 
alignment of MS1 features detected in multiple LC-MS runs. Quantification of peptide signals at 
the MS1 level enables the classification of features into enriched and background peptides, even 
in the absence of MS2 information. The specific peptide ion peaks without MS2 information can 
be used to generate inclusion lists for subsequent targeted LC-MS/MS analyses to increase 
specific peptide identification, and therefore improve specific protein identification and sequence 
coverage. 
The functional enrichment analysis helps us to obtain biological insight from Synphilin-1 
associated proteins. The most significant biological process that involves Synphilin-1 associated 
proteins is protein polymerization, which includes microtubule building blocks, (Figure 3-3A). 
This result indicates that elevating Synphilin-1 promotes microtubule polymerization. It has been 
shown that the formation of aggresomes was blocked by inhibiting microtubule polymerization, 
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and this led to decreased viability in cells expressing aggresome-forming proteins
88
. Therefore, it 
is likely that cellular machinery enhances microtubule polymerization to promote retrograde 
transport of toxic protein aggregates upon overexpression of Synphilin-1, in order to reduce 
cellular toxicity. These interactions may reflect transport of Synphilin-1 to the aggresome, since 
formation of aggresomes depends on microtubules. 
Histone deacetylase 6 (HDAC6) is an enzyme that catalyzes the deacetylation of lysine 
residues on histone and non-histone proteins, including tubulin, heat shock protein 90 (HSP90), 
and cortactin. Interestingly, HDAC6 was found to be associated with Synphilin-1 in our tandem 
affinity purification assay using immunoblotting (data not shown). Inhibition of HDAC6 results 
in high levels of α-tubulin acetylation at lysine 40 and a consequent increase in motor protein 
binding and microtubule-dependent transport
129
. Acetylation of tubulin enhances microtubule 
stability
130
. Expectedly, an increase in microtubule-dependent transport would facilitate dynein-
mediated aggresome formation. However, inhibition or deletion of HDAC6 blocks aggresome 
formation
131
. Further studies will be necessary to determine whether association of Synphilin-1 
and HDAC6 is involved in acetylation state of tubulin and aggresome formation.   
Another highly significant biological process that involves Synphilin-1 enriched proteins 
is chromatin assembly and disassembly, which engages chromodomain-helicase-DNA-binding 
protein (CHD family members such as CHD1, CHD2, and CHD8), Nucleophosmin (NPM), and 
Histone components (such as H3L and H4). The CHD family is characterized by the presence of 
chromo domains and SNF2-related helicase/ATPase domains. CHD proteins regulate gene 
expression by remodeling chromatin structure to enhance the chromatin accessibility, and 
therefore promote active transcription
132
.  NPM is a histone chaperone, and is required for the 
correct assembly/disassembly of nucleosomes, and therefore is necessary for DNA-dependent 
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activities like transcription, replication and repair
133
. Thus, association of Synphilin-1 and 
chromatin modulators may help to regulate gene expression and transcription in response to the 
stress of accumulation of misfolded proteins. Interestingly, NPM could recognize and bind to an 
unfolded nucleolus protein aggregate and temporarily remove it from the aggregation pathway. 
Phosphorylation of the NPM by casein kinase II (CK2) promotes the release of the unfolded 
substrates, which can be refolded after its release
134
. Our data may indicate that Synphilin-1 
interacting proteins NPM and CK2 may be involved in refolding of protein aggregates.  
Translational elongation and translation are two other significant biological processes that 
involve Synphilin-1 associated proteins. Translation is a cellular metabolic process in which a 
protein is formed, using the sequence of a mature mRNA molecule to specify the sequence of 
amino acids in the polypeptide chain. Translation is mediated by the ribosome. As a part of 
translation, translational elongation is involved in the successive addition of amino acid residues 
to a nascent polypeptide chain during protein biosynthesis. These two categories contain 
ribosomal proteins and elongation factor 1-alpha 1(EF1A1). EF1A1 promotes the GTP-dependent 
binding of aminoacyl-tRNA to the ribosomes during protein biosynsthesis. Association of 
Synphilin-1 with ribosomal proteins and EF1A1 shows the possibility that Synphilin-1 plays a 
role in regulation of translation under cellular stresses. 
Functional enrichment indicated that Synphilin-1 enriched proteins are involved in a 
series of RNA metabolic processes, including mRNA metabolism, RNA splicing, RNA 
processing. In this group, Putative pre-mRNA-splicing factor ATP-dependent RNA helicase 
DHX15 (DHX15) is a pre-mRNA processing factor involved in disassembly of spliceosomes 
after the release of mature mRNA. The zinc finger protein ZNF768 is involved in transcriptional 
regulation. The 40S ribosomal protein S24 is required for processing of pre-rRNA and maturation 
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of 40S ribosomal subunits. Heterogeneous nuclear ribonucleoproteins (hnRNPs) are complexes of 
RNA and protein that are present in the cell nucleus during gene transcription and subsequent 
post-transcriptional modification of the newly synthesized RNA (pre-mRNA). They prevent 
folding of pre-mRNA into secondary structures that inhibit its interactions with other proteins, 
association with the splicing apparatus, and transport of mRNA out of the nucleus. Cleavage and 
polyadenylation specificity factor subunit 7 (CPSF7) is a component of the cleavage factor Im 
complex (CFIm) that plays a key role in pre-mRNA 3’ processing. Putative RNA-binding protein 
15B (RBM15B) may function in the regulation of alternative or illicit splicing. Splicing factor 3B 
subunit 2 (SF3B2) is a subunit of splicing factor SF3B required for “A” complex assembly that is 
formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. 
Heat shock 70 kDa protein 1A/1B (HSP71), in cooperation with other chaperones, stabilizes pre-
existent proteins against aggregation and mediates the folding of newly translated polypeptides in 
the cytosol as well as in organelles. These chaperones participate in all these processes through 
their ability to recognize nonnative conformations of other proteins. They bind extended peptide 
segments with a net hydrophobic character exposed on polypeptides during translation and 
membrane translocation, or following stress-induced damage.  
Protein folding is a cellular protein metabolic process that assists in the covalent and 
noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct 
tertiary structure. We identified four proteins with this type of function:  heat shock cognate 71 
kDa protein (HSP7C), 60 kDa heat shock, mitochondrial (CH60), and Stress-70 protein, 
mitochondrial (GRP75), and RuvB-like 2 (RUVB2). Unlike other heat-inducible heat shock 
protein 70 (HSP70) family members, HSP7C is a constitutively expressed member. HSP7C binds 
to nascent polypeptides to facilitate correct protein folding. GRP75 is a non-heat- shock inducible 
protein in the HSP70 family and is assigned multiple functions ranging from stress response, 
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including the translocation of proteins from the cytosol into the matrix and their subsequent 
folding
135
. CH 60 is also a heat shock protein that is implicated in mitochondrial protein import 
and macromolecular assembly. It facilitates the correct folding of imported proteins, prevents 
misfolding and promotes the refolding and proper assembly of unfolded polypeptides generated 
under stress conditions in the mitochondrial matrix. RUVB2 is classified for protein folding, yet it 
is a part of chromatin-remodeling complexes. Together with RUVB1, it regulates the accessibility 
of DNA to the proteins involved in transcription and DNA damage repair
136
. It has been 
suggested that RUVBs may have a chaperone-like function, possibly by assisting in the folding 
and oligomeric assembly of protein in ATP-dependent reactions
137
. 
We find it interesting that Synphilin-1 enriched proteins are involved in gene and protein 
expression, all the way from chromatin modulation, RNA metabolic process, translation, and 
protein folding. This indicates that the Synphilin-1 complex may regulate gene and protein 
expression under protein misfolding stress, to decrease unfolded proteins in order to reduce cell 
toxicity. 
In terms of molecular functions extracted from functional enrichment analysis, it is not 
surprising to find that Synphilin-1 associated proteins exhibit nucleotide binding, chromatin 
binding, RNA binding, and serve as structural constituents of ribosomes (Figure 3-3B). Because 
many Synphilin-1 enriched proteins are involved in biological processes related to gene 
expression, including chromatin modulation, RNA metabolism, translation, and protein folding, 
these proteins exhibit binding domains to their substrates. The most significant molecular 
function of this set of proteins is their role as structural molecules in which the proteins contribute 
to the structural integrity of a complex or assembly, within or outside a cell. This is due to the 
presence of tubulins and ribosomal proteins. Interestingly, the binding of unfolded proteins shows 
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up as another highly significant molecular function. This group includes heat shock proteins such 
as HSP7C, HSP71, GRP75, GRP78, and CH60, that facilitate folding and re-folding of unfolded 
proteins, as discussed previously. NPM has been found to bind to an unfolded nucleolus protein 
aggregate and temporarily remove it from the aggregation pathway
134
. RUVB was suggested to 
have a chaperone-like function
137
. Enriched proteins with unfolded protein binding in the 
Synphilin-1 complex suggest the recruitment of molecular chaperones for correct refolding for 
misfolded proteins. 
We used Ingenuity pathway analysis to identify signaling and metabolic pathways, as 
well as cellular and disease processes, most relevant to our proteomic results (Figure 3-4B). The 
presence of various tubulin proteins provides evidence for the high significance of many 
signaling pathways, including germ cell-sertoli cell junction signaling and sertoli cell-sertoli cell 
junction signaling, gap junction signaling, 14-3-3 mediated signaling, breast cancer regulation by 
Stathmin1, and axonal guidance signaling. Ribosomal proteins have been reported to be involved 
in EIF2 signaling. Heat shock proteins (mainly HSP70s) were found to be present in many 
pathways, including aldosterone signaling in epithelial cells, eNOS signaling, the protein 
ubiquitination pathway, and Huntington’s disease signaling. Heat shock proteins are able to 
cooperate with the ubiquitin-proteasome system to determine protein fate by sorting between 
protein refolding or protein degradation. HSP70 participates in the degradation of aggregate-
prone proteins, such as the cystic fibrosis transmembrane conductance regulator (CFTR)
138
. 
Furthermore, overexpression of HSP70 levels can reduce aggresome formation by stimulating 
proteasomal degradation
139
. Thus it appears that aggresomes are major sites of chaperone–
proteasome cooperation to mediate the disposition of misfolded proteins. 
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The Synphilin-1interaction network was generated using Ingenuity pathway analysis of 
our proteomic results. We have found that Synphilin-1 associates with HSP70 (Figure 3-4B). In 
conjunction with other heat shock proteins, HSP70 stabilizes existing proteins against aggregation 
and mediates the folding of newly translated proteins in the cytosol and in organelles. It is also 
involved in the ubiquitin-proteasome pathway. It has been reported that elevated expression of 
HSP70 suppresses the toxicity of the α-synuclein in the Drosophila model of Parkinson disease, 
without inhibiting aggregate formation
140
. Hsp70s are abundantly present in, and are actively 
recruited to, aggresomes
141
.  Furthermore, elevated cellular Hsp70 levels can reduce aggresome 
formation by stimulating proteasomal degradation
139
. HSP70 binds to the 26S proteasome to 
increase activity of the 26S proteasome complex
142
 and decreases dysfunction of the active 26S 
proteasome complex
143
. This promotes the degradation of ubiquitinated proteins. Interestingly, 
Synphilin-1 interacts with the regulatory proteasomal protein S6 ATPase and decreases the 
activity of the human 26S proteasome which is associated with a significant increase in inclusion 
formation
104
. Therefore, further investigation of Synphilin-1 and HSP70 involvement in 
regulation of proteasome and protein degradation may contribute to discernment of the 
mechanism of aggresome formation. 
The Nuclear factor kappa B (NFkB) protein complex controls the transcription of DNA. 
NFkB is important in regulating cellular responses to harmful stress. NFkB interacts with many 
proteins (e.g. CK2) in Synphilin-1 interaction networks generated by Ingenuity network analysis 
(Figure 4B). It has been reported that activation of NFkB is required for the formation of 
aggresome-like induced structures 
144
. Moreover, NFkB activity is affected by CK2 
phosphorylation of the NFkB complex
145
, and inhibition of the proteasome by MG132 decreases 
activation of the NFkB complex
146
. Therefore, our results suggest that further investigation of the 
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correlation between NFkB activity and aggresome-like inclusions regulated by CK2 
phosphorylation could be worthwhile.  
Our tandem affinity purification, used in combination with label-free quantitative mass 
spectrometry, identified 57 Synphilin-1 associated proteins. Functional enrichment and pathway 
analysis help to better understand biological processes and molecular functions, as well as 
signaling and metabolic pathways that may involve the Synphilin-1 complex. Synphilin-1 
network analysis hints at the roles of several potential players in aggregate/aggresome formation, 
among which CK2 has been demonstrated as a key player. Further investigation of other 
Synphilin-1 interacting proteins could pave the way to unveiling of the mechanism(s) of 
aggregate/aggresome formation. This will contribute toward understanding of protein misfolding 
disorders, including Parkinson disease, and help to develop therapies for neurodegenerative 
diseases. 
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Chapter 4 : Application of chemical cross-linking in combination of mass spectrometry 
to the study Synphilin-1 interacting networks 
4.1 Introduction 
As our life expectancy increases, the chances of getting a neurodegenerative diseases like 
Alzheimer disease (AD), Parkinson disease (PD), and Huntington disease (HD) also increases. 
The major neurodegenerative diseases are caused by the aggregation of misfolded proteins
93
. 
These soluble misfolded proteins are either re-folded by molecular chaperones or degraded by the 
ubiquitin-proteasome system (UPS)
85
. When misfolded proteins overwhelm the capacities of 
molecular chaperones and the UPS systems, these abnormal proteins accumulate in the cytoplasm 
to form aggregates and lead to cell toxicity. To reduce cell toxicity, these protein aggregates can 
be loaded to dynein and retrograde transported through microtubules to aggresomes
86
.  
Aggresomes  are cellular protective perinuclear organelles that sequester toxic protein aggregates 
and are actively involved in refolding and proteasomal or autophagic degradation
89
. Thus, 
investigation of structures and functions of proteins that involves in aggregate/aggresome 
formation can help to delineate the mechanisms of aggregate/aggresome formation, understand 
pathogenesis of protein misfolding disorders, and develop effective therapies for 
neurodegenerative diseases. 
Synphilin-1 has been reported to associate with α-synuclein to form protein inclusions97 
and has been implicated in the pathogenesis of Parkinson disease. Expression of Synphilin-1 in 
mammalian cells leads to protein aggregation, which are transported to form aggresomes upon 
proteasome inhibition
98
. This demonstrated that Synphilin-1 plays an important role in the 
formation of aggregates and aggresomes. Synphilin-1 is a single polypeptide composed of 919 
amino acid residues organized into five domains that have been designated as follows: N-
terminus (residues 1-348), ANK1 (ankyrin-like repeat domain 1, residues 348-504), CC (coiled-
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coil domain, residues 505-560), ANK2 (ankyrin-like repeat domain 2, residues 561-728), and C-
terminus (729-919) (Figure 4-1, full length). CC and ANK domains are common protein 
structural motifs and mediate protein-proteins interactions. Previously, we have found that 
combination of CC and ANK2 is responsible for formation of protein aggregates in Synphilin-1 
expressed HEK293T cells, whereas ANK1 is necessary for formation of aggresomes upon 
proteasome inhibition
98
.  This result suggested other proteins bind to Synphilin-1 and participate 
in aggregate/aggresome formation pathways. Thus, the investigation of Synphilin-1 interacting 
proteins and their interacting domains would help to discern the cellular functions of Synphilin-1 
and the molecular mechanisms of aggregate/aggresome formation.  
Synphilin-1 forms dimers and interacts with α-synuclein via its central coiled-coil 
domain
99
. Synphilin-1 has been reported to bind to various proteins, including PARK2
86a, 91, 100
, 
SIAH1
100d, 101
, SNCA
97, 99, 100e, 100g, 102
, Ubiquitin
86a
, PIN1
102a
, UBC
100b, 100d, 100g, 101b, 103
, PSMC4
104
, 
SIAH2
100d, 101a, 105
, GET4
106
, PTN
106
, SH2D3C
106
, AES
106
, AGXT
106
, C11of58
107
, CSNK2B
108
, 
GSK3B
105
, NUDT21
107
, PPP1CA
109
, HERPUD1
110
, PINK1
100e
, RNF19A
103c
, STUB1
111
, UBD
100f
, 
and YWHAB
105
. To investigate aggregate/aggresome mediators, we used a minimal deletion of 
Synphilin-1 in this study, which depleted both the N-terminal and C-terminal regions of 
Synphilin-1, and therefore reduced the number of Synphilin-1 interacting proteins that are 
unrelated to aggregate/aggresome formation (Figure 4-1, ANK1-CC-ANK2). 
Proteomic analysis of complexes formed by Synphilin-1 has never been performed. 
Previously, we used tandem affinity purification (TAP) in combination with label-free 
quantitative mass spectrometry to map Synphilin-1 interaction networks (As shown in section 
3.3.4). Fifty-seven proteins significantly associated with Synphilin-1 were identified and have 
been subjected to functional and pathway analysis in that work. However, neither affinity 
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chromatography nor co-immunoprecipitation allows distinguishing among the binary interactions 
of Synphilin-1 and interactions between other protein pairs within the multiprotein complexes 
which are pulled down with Synphilin-1 due to the further interactions of proteins present in the 
complex. To determine binary interacting partners of Synphilin-1, chemical cross-linking and 
mass spectrometry were employed in this work. 
Protein cross-linking in combination with mass spectrometry has become a powerful 
method to investigate protein conformation and protein-protein interactions
115d, 147
 since it 
provides information on the spatial proximity among protein residues. The developments in mass 
spectrometry, isotopically tagged cross-linkers
148
, and sophisticated search algorithms
149
, make 
feasible the identification of cross-linked peptides within complex biological samples. Here we 
developed an isotopic tagging cross-linking strategy on Cobalt/His-tag affinity beads followed by 
mass spectrometry to identify the binary interacting partners with Synphilin-1 and to determine 
their interaction domains. The results reveal that most direct binding partners of Synphilin-1are 
involved in RNA metabolism, and thus indicate that Synphilin-1 could participate in RNA 
metabolism. In addition, we have determined that Synphilin-1 exclusively uses its aggregate-
promoting domain to bind to these interacting proteins. 
4.2 Experimental 
4.2.1 Materials  
All chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) 
unless mentioned otherwise.  
4.2.2 Cross-linking of standard proteins 
Bovine serum albumin, Carbonic anhydrase 2 (Bovine), Lysozyme C (Chicken), and 
Cytochrome C (Horse) were dissolved in water to 10 mg/ml. The cross-linker BS
3
 was dissolved 
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in water (Creative Molecules Inc. BC, Canada) as a 50 mM stock solution. Proteins were cross-
linked in 20 mM HEPES, pH 8.3, at room temperature for 1 h. The reaction was quenched by 
addition of ammonium-bicarbonate to a final concentration of 100 mM. 
4.2.3 Alkylation, reduction, digestion of cross-linked standard proteins 
The cross-linked protein mixture was reduced with 50 mM dithiothreitol (DTT) at 50 °C 
for 30 min, and alkylated with 100 mM iodoacetamide at room temperature in the dark for 30 
min. Additional DTT was added to quench excess iodoacetamide. For digestion, 5% acetonitrile 
(ACN), urea (1M final concentration), and 1:50 w/w trypsin (Promega, Madison, WI, USA) were 
added. Digestion was done overnight at 37 °C and stopped by 1% trifluoroacetic acid (TFA). 
Peptides were desalted with C18 MacroSpin columns (The Nest Group, Southborough, MA, 
USA). Peptides were evaporated to dryness using a Speed Vac™ (Thermo Fisher Scientific, 
Waltham, MA, USA). Peptides were either directly analyzed by LC-MS/MS or fractionated with 
strong cation exchange chromatography (SCX) to enrich cross-linked peptides prior mass 
spectrometry analysis. 
4.2.4 SCX for enriching standard cross-linked peptides 
MicroSpin columns (The Nest Group, Southborough, MA, USA) were used. The SCX 
columns were conditioned with 100% methanol, washed with water, and afterwards incubated 
with 300 mM ammonium acetate for 1 h. The columns were then equilibrated with 5% ACN, 
0.5% formic acid (FA). One hundred μg of the peptide mixtures were acidified with 5% ACN/ 
0.5% FA and loaded on the column. The columns were washed with 5% ACN/0.5% FA, and a 
stepwise elution was performed with the volatile eluant ammonium acetate with increasing 
concentration in 25% ACN and 0.1% FA. Eluted peptides were dried in a Speed Vac™ (Thermo 
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Fisher Scientific, Waltham, MA, USA), and then desalted with C18 MacroSpin columns (The 
Nest Group, Southborough, MA, USA). 
4.2.5 LC-MS/MS of standard cross-linked peptides 
For Synphilin-1 cross-linked samples, LC-MS/MS analysis was performed on a 
nanoACQUITY UPLC (Waters, Milford, MA, USA) online coupled to a LTQ-Orbitrap
TM
 mass 
spectrometer (Thermo Scientific, San Jose, CA, USA) with a TriVersa NanoMate (Advion, 
Ithaca, NY, USA) chip-based electrospray ionization source. Samples were suspended in 1% 
ACN/0.1% FA in HPLC-grade water and loaded to the UPLC system. The peptides were first 
trapped on a 180-µm x 20 mm, 5-µm particle size Symmetry@C18 trapping column (Waters, 
Milford, MA, USA) at a flow rate of 15 µl/min with 98% buffer A (1% ACN/0.1% FA in HPLC-
grade water) and 2% buffer B (99% ACN/0.1% FA in HPLC-grade water) for 1 min, and then 
separated on a 150 µm x 100 mm, 1.7-µm particle size BEH130 C18  analytical column (Waters, 
Milford, MA, USA) by a gradient from 2% - 50% of buffer B at 500 nL/min flow rate for 65 min 
and wash at 80% for 6 min. Two LTQ-Orbitrap
TM
 methods were used to perform targeted MS2 
fragmentation on isotopically tagged peptide pairs: a mass tags method and an inclusion list 
method. For the mass tags method, the mass spectrometer was set to search a mass shift of 
12.07573 Da at different charge states on the same pre-scan, and fragment the peak pairs. For the 
inclusion list method, an LC-MS run was performed, and the MS ions were extracted using 
Progenesis LC-MS software (version 4.04441.29989, Nonlinear, Durham, NC, USA). The cross-
linked peptide pairs were extracted using an in-house built algorithm, XLPairExtraction (software 
was written by Han Hu and Xiaobin Xu, Boston University, as described in Section 4.3.2), to 
generate an inclusion list. The inclusion list was imported into the Orbitrap setup from the prior 
LC-MS/MS run to perform targeted fragmentation on cross-linked peptide pairs. From the high 
resolution MS pre-scan, the top three most abundant peptide ions were selected for MS/MS. 
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Singly charged peptides were excluded from this analysis. The normalized collision energy for 
higher energy collision-induced dissociation (HCD) was set to a value of 30eV with an isolation 
width of 3 u. 
4.2.6 Constructs, cells cultures, transfection 
For affinity purification, we employed the pEGFPN1 plasmid with cloned depletion #6 of 
human Synphilin-1 (from amino acid residue 349 to 729) with a His-tag at the N-terminus and a 
GFP-tag at the C- terminus, as described previously
98
.  
HEK293T (human embryonic kidney) cells were grown in Dulbecco’s modified Eagle’s 
medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum 
(FBS) at 37 °C in an atmosphere of 5% CO2. Cells were transfected using Lipofectamine 2000 
reagent (Life Technologies, Carlsbad, CA, USA) with depletion 6 of Synphilin-1, according to 
the manufacturer’s instructions. Cells were harvested and stored at -20 °C until lysis.  
4.2.7 Cell lysis and cross-linking 
All the following procedures were performed at 4 °C. Cells were lysed with lysis buffer 
composed of 6xHis wash buffer (BD Bioscience, San Jose, CA, USA), supplemented with 1% 
Triton X-100, 20 mM imidazole, 10 mM NaF, 10 mM β-glycerophosphate, 10 mM sodium 
orthovanadate, 1 mM PMSF, His-protease inhibitor cocktails, and Tyrosine/alkaline phosphatase 
inhibitor cocktails. Samples were adjusted to have equal concentrations of total protein. 
Protein extracts from thirty 15-cm
2
 tissue cell culture dishes with 90% confluence of each 
sample were incubated with 1500 µl of HisPur cobalt resin (Pierce, Rockford, IL, USA) for 30 
min with rotation. Samples were passed through the same cobalt resin three times and washed 
with lysis buffer five times. Samples were washed with 50 mM HEPES (pH 7.4) five times. To 
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the sample, 3000 μl of 4 mg of BS3-H12/D12 (BisSulfoSuccinimidylSuberate) (Creative Molecules 
Inc., BC, Canada) and incubated with rotating at room temperature for 1 h. The cross-linking 
reaction was quenched using 100 mM Tris-HCl. The sample was washed with 8 M urea twice to 
remove non-cross-linked proteins. The sample was eluted with 6xHis elution buffer (BD 
Bioscience, San Jose, CA, USA) supplemented with 500 mM imidazole. Samples were stored at -
80 °C before subsequent analysis. 
4.2.8 Gel-filtration, digestion, SCX, and C18 reversed phase spin column desalting 
To remove imidazole in the eluate, buffer exchange was performed with 100 mM 
ammonium bicarbonate using PD-10 desalting columns (GE Healthcare, Piscataway, NJ, USA).  
Samples were reduced with 50 mM dithiothreitol (DTT) for 30 min at 30 ºC, and alkylated with 
100 mM iodoacetamide for 30 min in the dark at room temperature. Alkylation was quenched 
with 100 mM DTT. The proteins were digested with trypsin (Promega, Madison, MI, USA) (1:50 
(w/w), trypsin: protein) and samples were incubated at 37 °C for 16 h. Digestion were quenched 
by 1% trifluoroacetic acid (TFA) and desalted with C18 RP MacroSpin™ columns (The Nest 
Group, Southborough, MA, USA) using the manufacturer’s instructions. Peptide mixtures were 
evaporated to dryness using a Speed Vac™ (Thermo Fisher Scientific, Waltham, MA, USA). The 
peptide mixtures were fractionated and enriched with strong cation exchange chromatography 
(SCX) MacroSpin
TM
 columns (The Nest Group, Southborough, MA, USA). The SCX columns 
were conditioned with 100 % methanol, washed with water, and afterwards incubated with 300 
mM ammonium acetate for 1 h. The columns were then equilibrated with 5% ACN/0.5% FA. The 
peptide mixtures were re-suspended with 5% ACN/0.5% FA and loaded on the column. The 
column was washed with 5% ACN/0.5 % FA, and a stepwise elution was performed with 10 mM, 
20 mM, 40 mM, 60 mM, 80 mM, 100 mM, 150 mM, 200 mM, 300 mM, and 600 mM ammonium 
acetate in 25% ACN and 0.1% FA. Each SCX eluate was desalted with C18 RP MacroSpin™ 
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columns (The Nest Group, Southborough, MA, USA) using the manufacturer’s instructions.  The 
samples were evaporated to dryness using a Speed Vac™ (Thermo Fisher Scientific, Waltham, 
MA, USA), and stored at -80 °C until LC-MS/MS analysis.  
4.2.9 Reversed phase liquid chromatography and mass spectrometry 
For Synphilin-1 cross-linked samples, LC-MS/MS analysis was performed on a 
nanoACQUITY UPLC (Waters, Milford, MA, USA) online coupled to a Q-Exactive mass 
spectrometer (Thermo Scientific, San Jose, CA, USA) with a TriVersa NanoMate (Advion, 
Ithaca, NY, USA) chip-based electrospray ionization source. The samples were separated by C18 
reversed phase UPLC as described before for analysis of standard cross-linked peptides. The 
eluting peptides were analyzed by the Q-Exactive using data dependent analysis (DDA). From the 
high resolution MS pre-scan, the top ten most abundant peptide ions were selected for fragment 
ion analysis if they exceeded an intensity of 8.3e4. Singly charged peptides were excluded from 
this analysis. The normalized collision energy for higher energy collision-induced dissociation 
(HCD) was set to a value of 30 with an isolation width of 3 u. Every ion selected for 
fragmentation was excluded for the next five sec by dynamic exclusion. 
4.2.10 Database search and protein identification 
The acquired spectra (Thermo .raw files) were imported to Thermo Proteome Discoverer 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) (Version 1.3.0.399) and searched against 
Uniprot/Swissprot 57.15 (Release 2011_10, Taxonomy, Homo sapiens; protein entries, 20,266) 
for peptide identification using Mascot (version 2.3.2) (Matrix Science Ltd.). The following 
Mascot search parameters were used: enzyme, trypsin; two missed cleavages allowed; static 
modification, carbamidomethyl (C); dynamic modifications, oxidation (M) and deamidated (NQ); 
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peptide mass tolerance, 5 ppm; fragment ion mass tolerance, 0.5 Da; decoy database search 
enabled; target false discovery rate (FDR) (strict), 0.01; target FDR (relaxed), 0.05. 
4.2.11 Assignment of cross-linked peptides 
xQuest was used to assign cross-linked peptides as well as their specific cross-linking 
residues
149a
. xQuest requires three input files, a Mascot generic format (mgf) file containing 
spectra of interest, a list with paired spectra, and a fasta protein database. The fasta protein 
database was generated using Thermo Proteomic Discoverer (Thermo Fisher Scientific Inc., 
Waltham, MA, USA). To generate an mgf file containing spectra of interest, two in-house 
algorithms were developed, XLPairExtraction and XLmgfExtraction (Software were written by 
Han Hu and Xiaobin Xu, Boston University). XLPairExtraction is an R coded program that is 
used to extract precursor ion pairs of light and heavy cross-linked peptides from an MS1 peak list. 
XLmgfExtraction is a Python-coded program that is used to extract fragment ions of paired light 
and heavy cross-linked peptides from an MS2 peak list for xQuest search. All MS2 precursor ions 
were exported from Thermo Proteome Discoverer (Thermo Fisher Scientific Inc., Waltham, MA, 
USA). All MS2 spectra were exported as mgf files (Thermo Fisher Scientific Inc., Waltham, MA, 
USA). The heavy and light peaks of the cross-linked peptide pairs were extracted using 
XLPairExtraction based on the following criteria: Δ mass, 12.07573 u; Δ charge state, 0; Δ 
retention time, 0.15 min; Δ intensity, ≤ 30%.  The paired heavy and light cross-linked peptide 
fragment ion lists were extracted using XLmgfExtraction via their unique scan numbers in the 
peak lists of the cross-linked peptide pairs. The following xQuest search parameters were used: 
enzyme, trypsin; min. number of amino acids (AAs) per peptide, 3; max. number of AAs per 
peptide, 40; two missed cleavages allowed; fixed modification, carbamidomethyl (C); variable 
modifications, oxidation (M); xlink mass-shift, 138.0680796; monolink mass-shift(s), 
156.0786442, 155.0964278; isotopic shift, 12.07573; reactive amino acids, K; MS1 tolerance, 5 
107 
 
 
ppm; MS2 tolerance, 0.2 m/z; xlink ms2 tolerance, 0.3 m/z; min. m/z fragment-ion size, 100; max. 
m/z fragment-ion size, 3000; select fragment-ion types, a, b, y; threshold (absolute) for peak 
intensities, 1; dynamic range of peak intensities, 5000. 
4.2.12 Functional enrichment analysis 
Classification and functional enrichment analyses of the cross-linked proteins were 
performed using Database for Annotation, Visualization and Integated Discovery™ (DAVID)127 
for the biological process (BP), molecular function (MF). 
4.3 Results and discussion 
4.3.1 Development of isotopically tagged cross-linking protocols using standard proteins 
Four standard proteins, serum albumin (bovine) (BSA), carbonic anhydrase 2 (bovine), 
lysozyme C (chicken), cytochrome c (horse), were used for development of isotopically tagged 
cross-linking protocols. These standard proteins were cross-linked with a mix of light (D0) and 
heavy (D12) labeled Bis[sulfosuccinimidyl] suberate (BS
3
). After enzymatic digestion, the light 
and heavy BS
3
 modified peptides have unique doublet peaks, which have a mass difference of 12 
Da. Two mass spectrometry strategies, a mass tags method and an inclusion list method, were 
used to perform targeted MS2 fragmentation on isotopically tagged cross-linker modified 
peptides. To utilize the mass tags method, the LTQ-Orbitrap
TM
 was only allowed to look for a 
pair of peaks differing by 12.07573 Da at different charge states and fragment both light and 
heavy isotopic peaks. The resulting 121 isotopically tagged cross-linker modified peptide pairs 
were extracted from 668 MS2 spectra using our in-house IsoPairExtraction program. Fourteen 
pairs with a charge state ≥ 4+ were searched against xQuest, and five cross-linked peptides and 
two loop-linked peptides were thereby assigned (Table 4-1). Figure 4-2 shows the cross-linking 
between two BSA peptides as an example. To utilize the inclusion list method, the sample was 
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first analyzed using the data dependent acquisition mode. The MS1 peaks were extracted using 
Progenesis LCMS. The isotopically tagged cross-linker modified peptide pairs were extracted 
using in-house IsoPairExtraction program, and exported as an inclusion list in the second LC-
MS/MS analysis. The resulting 202 isotopically tagged cross-linker modified peptide pairs were 
extracted from 1814 MS peaks with a charge state ≥ 3+ and used as an inclusion list. Fifty-one 
pairs from the inclusion list were fragmented. Fifteen pairs with a charge state ≥ 4+ were 
searched against xQuest, and 6 cross-linked peptides and one loop-linked peptide were thereby 
assigned (Table 4-2). Strong cation exchange chromatography (SCX) was used to enrich cross-
linked peptides. Because cross-linked peptides behave like the sum of two independent peptides 
with a total of two basic tryptic C-termini, they are present as more highly charged ions under 
acidic conditions. These highly charged cross-linked peptides are eluted with higher salt 
concentrations. Therefore, they can be partially separated from non-modified peptides. SCX 
fractionations enriched putative cross-linked peptides with high precursor charge states (Figure 4-
3).  
 
Figure 4-1. A scheme of constructs of Synphilin-1. Ankyrin-like repeat domain 1 (ANK1) is 
the aggresome-targeting signal region; ANK2 together with the coiled-coil domain (CC) 
constitute the aggregation-promoting region. Construct ANK1-CC-ANK2 was used in this study. 
NT, N terminus; CT, C terminus. 
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Figure 4-2. MS2 spectra of two cross-linked BSA peptides. MS2 spectrum of light cross-linked 
peptide at m/z 739.12883 (4+) (upper panel) and MS2 spectrum of heavy cross-linked peptide at 
m/z 742.14724 (4+) (bottom panel).  Common fragment ions are labeled in green and isotopically 
labeled fragment ions are labeled in red. The cross-linking sites can be determined as the K235 
residue on the A233-R241 BSA peptide and the K374 residue on the L372-K386 BSA peptide. 
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Figure 4-3. Distribution of cross-linked ion pairs from standard peptides during SCX 
elutions. Cross-linked peptides carrying two basic C-termini exhibit higher charge states and tend 
to be eluted at higher salt concentrations. 
4.3.2 In-house algorithms for automated data processing 
LC-MS/MS of cross-linked peptide mixtures generates a large data set, and thus 
manually checking for light and heavy peptide peaks becomes time and labor consuming, if not 
impossible. To address this issue, two in-house algorithms were developed for automated LC-
MS/MS data processing.  
The first program was written in R language and is called XLPairExtraction; extracts 
precursor ion pairs of light and heavy cross-linked peptides from an MS1 peak list. This program 
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can be used to generate an inclusion list for targeted MS/MS fragmentation on H/L cross-linked 
peptides. It can also be used to generate a list of the H/L cross-linked peptide pairs for xQuest 
search. XLPairExtraction uses several criteria to pair the heavy and light cross-linked peptides: 
mass shift, charge state, retention time and signal intensity. 
The second program was written in Python language and is called XLmgfExtraction; it 
extracts fragment ions corresponding to paired light and heavy cross-linked peptides from an 
MS2 peak list for xQuest search. XLmgfextraction searches unique scan numbers from the cross-
linked peptide precursor peak list generated by XLPairExtraction, and uses these scan numbers to 
extract the fragment ions list from the mgf file generated using Proteome Discoverer. The output 
files are paired light and heavy cross-linked peptide fragment ion lists that can be directly used 
for xQuest search. 
4.3.3 Determination of Synphilin-1 binary interactions using isotopically tagged cross-
linking and mass spectrometry 
To demonstrate that our strategy has the capability to detect protein interactions in 
complexes, we first investigated the cross-linking between some well-studied protein interaction 
partners found in our Synphilin-1 pull-down: NONO, SFPQ, and PSPC1. These three proteins 
belong to Drosophila Behavior Human Splicing (DBHS) family and the core protein components 
of paraspeckles
150
. They are involved in many aspects of RNA synthesis and processing, 
including transcription initiation, transcriptional termination, and splicing
151
. We found that 
PSPC1 and NONO were cross-linked via lysine residues in their coiled-coil domains (K303 on 
PSPC1 and K249 on NONO) (Figure 4-4). This is in agreement with the reported crystal structure 
which showed that PSPC1 and NONO form an extensively intertwined heterodimer through their 
antiparallel coiled-coil domains
152
. In addition, it has been shown that PSPC1 requires its coiled-
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coil domain to pull down NONO, indicating that coiled-coil domain of PSPC1 is essential to 
interact with NONO
153
.  Other cross-links found between DBHS family members and literature 
reports that support our evidence for their interactions are listed in Table 4-4. Example MS2 
spectra of cross-linked peptides are shown in Figures 4-10 (NONO-SFPQ) and Figure 4-11 
(NONO-TOP1). Interactions between NONO and SFPQ have been intensively studied
151a, 151d, 154
. 
Interactions between NONO and TOP1 were also reported previously
154j, 155
. These results clearly 
demonstrate that our strategy has the capability to detect and identify binary protein interactions. 
The proteomic analysis of the cross-linked Synphilin-1 complex aims to determine 1) the 
proteins that directly interact with Synphilin-1 in HEK293T cells, and 2) to map binding sites on 
these proteins and on Synphilin-1. To this end, the developed methodologies for isotopically 
tagged cross-linking and mass spectrometry were applied to determine Synphilin-1 interacting 
proteins pulled down on Cobalt/His-tag affinity beads. The experimental strategy is shown in 
Figure 4-5. We have previously utilized tandem affinity purification and label-free quantitative 
mass spectrometry to identified fifty-seven proteins as significantly associated with Synphilin-
1(As shown in section 3.3.4). In that work, we double tagged Synphilin-1 with histidine and GFP, 
and pull-down its associated proteins in tandem. These identified proteins include proteins 
directly and indirectly interacting with Synphilin-1(Table 4-3). We could not use the tandem 
purification strategy in this work because the cross-linker will covalently bind to GFP-antibodies 
and thus preventing elution of the interacting proteins. However, tandem affinity purification 
minimizes proteins that were either accidental contaminants or which bound non-specifically to 
the bait. The protein fasta database constructed for xQuest cross-linked peptide assignment was 
composed of proteins that are listed in Table 4-3. Using this strategy, we found 17 proteins that 
directly interacted with Synphilin-1, and evidence for Synphilin-1 dimerization (Table 4-4 & 
Figure 4-7).   
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We found that two Synphilin-1 peptides cross-linked with each other (Figure 4-6). Both 
alpha chain and beta chain peptides originated within or close to the central coiled-coil domain of 
Synphilin-1; this result indicated that Synphilin-1 dimerizes through its central coiled-coil domain. 
Indeed, it has been reported that Synphilin-1 dimerizes at its central coiled-coil domain and 
interacts with α-synuclein99.   
The other 16 proteins are involved in newly discovered interactions that have not been 
reported previously. To gain a general idea about the functions of these proteins, we performed 
functional enrichment, using DAVID to classify proteins that cross-linked with Synphilin-1 based 
on their biological process and molecular functions. Functional enrichment of the relevant 
biological processes indicates that Synphilin-1 cross-linked proteins are mostly involved in 
mRNA metabolic processes (6 proteins), especially, RNA splicing (4 proteins). Functional 
enrichment of molecular functions indicates that Synphilin-1 cross-linked proteins mostly have 
binding activities, especially nucleotide binding (12 proteins) and RNA binding (8 proteins). The 
functional enrichment analysis indicates that Synphilin-1 cross-linked proteins mainly participate 
in RNA processing. This implies that Synphilin-1 could form complexes with these proteins and 
affect RNA processing.  
It is interesting to find that Synphilin-1 cross-linked with other proteins through its 
coiled-coil domain (encompassing amino acids505-560) and ANK2 domain (encompassing 
amino acids561-726). Previously, we demonstrated that its coiled-coil and ANK2 domains 
together constitute the aggregation-promoting region of Synphilin-1
98
. Binding of proteins to this 
region of Synphilin-1 may indicate that Synphilin-1 recruits these proteins to regulate gene 
expression under conditions of cellular stress, such as proteasome inhibition, to control abnormal 
protein aggregation, most likely through regulation of RNA metabolism. 
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Synphilin-1 cross-linked proteins are involved in various stages of RNA metabolism 
(Table 4-4), including transcription (CHD1, Figure 4-8; NPM, Figure 4-12; RUVB1, Figure 4-13; 
CCNT1, Figure 4-14), pre-mRNA splicing (HNRPL, Figure 4-15; SF3B1, Figure 4-16; PRP4B, 
Figure 4-17), and 3’-end processing of pre-mRNA (CPSF7, Figure 4-18; FIP1, Figure 4-19; 
GPTC4, Figure 4-20). We also found that Synphilin-1 cross-linked to RNA-binding protein 33 
(RBM33), whose biological functions remain unknown. RBM33 contains an RNA recognition 
motif (RRM) at its C-terminus, indicating that it is mostly likely involved in RNA processing. 
Synphilin-1 binds to this RRM domain (Figures 4-21 & 4-22). Although RRM domains are 
named as such due to their ability to bind RNA, there is growing evidence for the role of RRM 
domains in protein-protein interactions
156
. Other than RBM33, CPSF7 also binds to Synphilin-1 
via its RRM domain (Figure 4-18). The cross-linked proteins are grouped based on their 
biological functions and are shown in Figure 4-7. The cross-linked sites on Synphilin-1are labeled 
next to the name of each protein. No full length Synphilin-1 crystal structure is available for 
protein docking studies. 
Four Synphilin-1 cross-linked proteins are involved in transcription control, including 
CHD1, NPM, RUVB1, and CCNT1. The Chromodomain-helicase-DNA-binding protein (CHD) 
family is characterized by the presence of chromo domains and SNF2-related helicase/ATPase 
domains. CHD proteins regulate gene expression by remodeling chromatin structure to enhance 
the chromatin accessibility, and therefore promote active transcription
132
.  CHD1 associated with 
several factors and regulates transcription elongation
157
. The cross-linking site on Synphilin-1 is 
Lys524, located at its central coiled-coil domain (Figure 4-30). Nucelophosmin (NPM) is a 
histone chaperone, which is required for the correct assembly/disassembly of nucleosomes, and 
therefore is necessary for DNA-dependent activities like transcription, replication and repair
133
. 
NPM is involved in numerous diverse cellular processes such as ribosome biogenesis
158
, 
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centrosome duplication
159
, protein chaperoning
160
, and transcriptional control
161
. RUVB1 
regulates the accessibility of DNA to the proteins involved in transcription and DNA damage 
repair
136
. Cyclin-T1 (CCNT1) is regulatory subunit of the cyclin-dependent kinase pair 
(CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), 
which is proposed to facilitate the transition from abortive to productive elongation by 
phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II 
(RNA Pol II). Therefore, cyclin-dependent kinases govern Pol II handoff from initiation to 
elongation factors and co-transcriptional RNA maturation
162
.  
After RNA biosynthesis, pre-mRNA needs to undergo splicing to remove non-coding 
introns to form mature mRNA. Three Synphilin-1 cross-linked proteins are involved in pre-
mRNA splicing, including HNRPL, SF3B1, and PRP4B. Heterogeneous nuclear 
ribonucleoprotein L (HNRPL) is one of the hnRNP proteins. hnRNP proteins direct their 
influence on pre-mRNA splicing through site-specific binding with the target RNA. After binding, 
the functional regions of hnRNPs (RGG boxes, glycine –rich, acidic or, proline-rich domains) 
then promote protein/protein interactions that ultimately mediate splicing decisions
163
. We found 
that the protein binding domain (ANK2) of Synphilin-1 cross-linked with the Gly-rich domain of 
HNRPL (Figure 4-15), implicating that Synphilin-1 could function as a splicing factor. The 
splicing factor 3B (SF3B) binds to U2 snRNA and pre-mRNA during the assembly of pre-
spliceosome formation for tethering the U2 snRNP to the pre-mRNA
164
. It has been suggested 
that the PRP4 kinase (PRP4B) is involved in control of the formation of active splicesomes
165
 to 
regulate pre-mRNA splicing reactions by phosphorylating certain splicing factors.   
In addition to splicing, cleavage and polyadenylation at the 3’-end of pre-mRNA is 
another pre-mRNA processing step; it promotes 1) the transport of mRNAs from the nucleus to 
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the cytoplasm, 2) the stability of mRNAs, 3) the translation of mRNAs into proteins. The 3’-end 
processing machinery, which contains several sub-complexes, also has important roles in 
transcription and splicing
166
. Three Synphilin-1 cross-linked proteins are involved in the 3’-end of 
pre-mRNA processing. The cleavage and polyadenylation specificity factor 7 (CPSF7) is a 
protein that belongs to the pre-mRNA 3’-end processing complex. The pre-mRNA 3’-end-
processing factor FIP1 (FIPL) is a component of the FPSF complex that plays a key role in pre-
mRNA 3’-end formation, recognizing pre-mRNA signal sequence and interacting with poly(A) 
polymerase and other factors to bring about cleavage and poly(A) addition
167
.  FIP1 could tether 
poly(A) polymerase to the CPSF complex. The G patch domain-containing protein 4 (GPTC4) 
contains a short conserved region of about 40 amino acids which occurs in number of putative 
RNA-binding protein
168
. The G-patch domain contains an RNA polymerase II C-terminal repeat-
binding domain seen in many proteins of the polyA-addition machinery
169
. Thus, like the RRM, 
the G-patch domain might perform a specific function in the polyadenylation complex. In 
summary, Synphilin-1 is implicated in mRNA processing, as illustrated in Figure 4-9. 
In addition to its binding to proteins involved in RNA metabolism, Synphilin-1 was 
found to bind to other proteins, including members of the heat shock protein 70 family (HSP71, 
Figure 4-23; HS71L, Figure 4-24; HSP7C, Figure 4-25 & 26), and tubulins (TBA1A or TBA1C, 
Figure 4-27; TBB2B, Figure 4-28). 
Synphilin-1 cross-linked with HSP71 (heat shock 70 kDa protein 1A/1B) with its protein 
binding domain ANK2.  HSP71 is a protein known to be present in Lewy bodies (LBs)
170
 and to 
prevent both protein aggregation and neurodegeneration
170a, 171
. In eukaryotes, gene expression 
can be regulated by the selective decay of mRNAs. HSP71 has been reported to negatively 
regulate mRNA degradation through the ubiquitin-proteasome pathway
172
.  HSP7C (Heat shock 
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cognate 71 kDa protein) is another heat shock protein that we found to be cross-linked with 
Synphilin-1 at its protein binding domain ANK2. Interestingly, both HSP71 and HSP7C are 
localized in cytoplasmic mRNP granules containing untranslated mRNAs
173
.  
Synphilin-1 cross-linked to α-tubulin (to a peptide that has an identical sequence in 
TBA1A and TBA1C) (Figure 4-27) and β (TBB2B) (Figure 4-28), indicating Synphilin-1 binds 
to microtubules. This result is consistent with our previous observation that formation of 
Synphilin-1 aggresomes were blocked by the microtubule poisons nocodazole or benomyl, 
resulting in accumulation of multiple aggregates
98
. 
 
Figure 4-4. MS2 spectra of cross-linked peptides from two well-known interacting partners, 
PSPC1 and NONO. 
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Figure 4-5. Work flow of determination of Synphilin-1 binary interactions using isotopically 
labeled cross-linking and mass spectrometry. 
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Figure 4-6. MS2 spectra of two Synphilin-1 peptides cross-linked within the coiled-coil 
domain. 
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Figure 4-7. Synphilin-1 interaction maps.Synphilin-1 cross-linked proteins are grouped based 
on their biological functions. The cross-linking sites on Synphilin-1 are labeled next to the protein 
names. The linkages have been drawn between Synphilin-1 binding domains and the protein 
groups. All observed interactions involve the CC and ANK2 domains on Synphilin-1, which have 
been proposed as the aggregate-promoting domain. 
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Figure 4-8. MS2 spectra of two peptides cross-linked between Synphilin-1 and CHD1. 
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Figure 4-9. Synphilin-1 is implicated in mRNA processing, from RNA biosynthesis, pre-
mRNA splicing, to cleavage and polyadenylation of pre-mRNA. 
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Figure 4-10. MS2 spectra of two peptides cross-linked between NONO and SFPQ. 
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Figure 4-11. MS2 spectra of two peptides cross-linked between NONO and TOP1. 
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Figure 4-12. MS2 spectra of two peptides cross-linked between Synphilin-1 and NPM. 
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Figure 4-13. MS2 spectra of two peptides cross-linked between Synphilin-1 and RUVB1. 
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Figure 4-14. MS2 spectra of two peptides cross-linked between Synphilin-1 and CCNT1. 
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Figure 4-15. MS2 spectra of two peptides cross-linked between Synphilin-1 and HNRPL. 
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Figure 4-16. MS2 spectra of two peptides cross-linked between Synphilin-1 and SF3B1. 
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Figure 4-17. MS2 spectra of two peptides cross-linked between Synphilin-1 and PRP4B. 
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Figure 4-18. MS2 spectra of two peptides cross-linked between Synphilin-1 and CPSF7. 
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Figure 4-19. MS2 spectra of two peptides cross-linked between Synphilin-1 and FIP1. 
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Figure 4-20. MS2 spectra of two peptides cross-linked between Synphilin-1 and GPTC4. 
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Figure 4-21. MS2 spectra of two peptides cross-linked between Synphilin-1 and RBM33. 
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Figure 4-22. MS2 spectra of two peptides cross-linked between Synphilin-1 and RBM33. 
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Figure 4-23. MS2 spectra of two peptides cross-linked between Synphilin-1 and HSP71. 
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Figure 4-24. MS2 spectra of two peptides cross-linked between Synphilin-1 and HS71L. 
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Figure 4-25. MS2 spectra of two peptides cross-linked between Synphilin-1 and HSP7C. 
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Figure 4-26. MS2 spectra of two peptides cross-linked between Synphilin-1 and HSP7C. 
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Figure 4-27. MS2 spectra of two peptides cross-linked between Synphilin-1 and TBA1A or 
TBA1C. 
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Figure 4-28. MS2 spectra of two peptides cross-linked between Synphilin-1 and TBB2B. 
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Figure 4-29. MS2 spectra of two peptides cross-linked between two Synphilin-1 peptides. 
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Figure 4-30. Crystal structure of Synphilin-1 coiled-coil domain (PDB:2KES ) shows the 
cross-linked site, LYS524, which is found to be cross-linked with CHD1 at LYS1435. Figure 
modified from Ref. (
99
). 
Table 4-1. Cross-linking of standard proteins using mass tag method. 
  
Table 4-2. Cross-linking of standard proteins using inclusion list method. 
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Table 4-3. Tandem affinity purification enriched Synphilin-1 associated proteins. 
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Table 4-4. List of cross-linked proteins with Synphilin-1. Table shows cross-linked 
proteins/peptides as well as the cross-linked sites/domain found using our developed isotopically 
tagged cross-linking and mass spectrometry methodology. CC, coiled-coil domain; ANK, ankyrin 
repeat; RRM, RNA recognition motif; CT, C-terminus; HEAT, HEAT repeat domain. 
 
4.4 Conclusions 
A mass spectrometry strategy using affinity purification in combination with isotopically 
tagged cross-linking has been established for use in protein-protein interaction studies and was 
successfully applied to investigate binary interactions with Synphilin-1. Using this approach, 17 
interacting proteins, direct interacting protein partners of Synphilin-1 (including 16 novel 
interactions) have been detected and assigned. The adjacent coiled-coil domain (CC) and ankyrin-
like repeat domain 2 (ANK2) of Synphilin-1 was revealed as the main region that bound 
interacting proteins. The proteins for which cross-links were detected are mainly involved in 
RNA metabolism; this result indicates Synphilin-1 may participate in RNA processing. Together 
with prior evidence for the role of Synphilin-1in aggregate/aggresome formation, the data we 
report here suggest the existence of a mechanism for Synphilin-1 regulation of abnormal protein 
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expression through RNA processing in response to cellular stresses, such as proteasome 
inhibition. These results strongly suggest that further investigation of Synphilin-1 involvement in 
RNA metabolism should be undertaken.  
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Chapter 5 : Biological functions of Synphilin-1 interactors involved in aggresome 
formation 
5.1 Introduction 
We have determined the Synphilin-1 interactors using tandem affinity purification and 
mass spectrometry (Chapter 3), and have the identified the Synphilin-1 direct interactors using 
isotopically tagged cross-linkers in combination with mass spectrometry (Chapter 4). Our 
functional enrichment and network analysis indicate the functionalities of Synphilin-1 and reveal 
a number of proteins that could be involved in the pathways of formation of small protein 
aggregates and/or aggresomes. How these proteins are involved in aggregate/aggresome 
formation and how Synphilin-1 functions in the evolution and activity of the aggresome become 
interesting issues.   
5.2 Protein kinase CK2 in aggresome formation 
CK2 is a serine/threonine protein kinase that exists as a tetramer and is composed of an α 
(CK2A1), an α' (CK2A2), and two β (CK2B) subunits. CK2A1 and CK2A2 are the catalytic 
subunits and CK2B is the regulatory subunit. Network analysis and immunoblotting 
demonstrated that protein kinase CK2 associates with Synphilin-1 and plays a potential regulatory 
role in aggresome formation (Figure 3-4B). As a central component of the network, CK2 has 
been reported to phosphorylate Synphilin-1 and its β subunit (CK2B) has been reported to bind 
Synphilin-1
108
.  In addition, inhibition of CK2 activity by DRB, a CK2 inhibitor, blocks binding 
between Synphilin-1 and α-synuclein, and reduces the percentage of cells that contain 
cytoplasmic inclusions
108
.  Therefore, investigation of the interactions of CK2 subunits with 
Synphilin-1 and the involvement of CK2 subunits in Synphilin-1 aggresome formation should be 
informative. Here we report that depletion of CK2 regulatory β subunits significantly reduced 
aggresome formation. In contrast, knockdown of the α or α’ subunits responsible for its catalytic 
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activity did not affect aggresome formation. These results indicate that CK2 is an important 
regulator of aggresome formation but does not regulate via its phosphorylation activities. 
5.2.1 Experimental methods 
5.2.1.1 Chemicals and antibodies 
All chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) 
unless mentioned otherwise.  
Antibodies against CK2A1 and CK2A2 were purchased from Abcam (Cambridge, MA, 
USA), the antibody against GFP was from Clontech (Palo Alto, CA, USA), and the antibodies 
against CK2B, α-tubulin, and actin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
5.2.1.2 Immunoblot analysis 
Protein solutions were combined with an equal volume of 2-fold Laemmli sample buffer 
(Bio-Rad, Hercules, CA, USA) and 5 % (v/v) 2-mercaptoethanol and the mixture was boiled for 
10 min at 95 °C. The proteins were then separated by a 4-12% NuPAGE gel (Life Technologies, 
Grand Island, NY, USA) and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, 
USA). Membranes were blocked for 30 min in blocking solution (5% milk in 1xTris buffered 
saline, 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 0.1% Tween-20) at room temperature and 
incubated with the appropriate primary antibody overnight at 4 °C, then incubated with 
horseradish peroxidase-conjugated secondary antibodies (Cell Signaling, Danvers, MA, USA); 
afterwards, the proteins were visualized using ECL reagents (Thermo Fisher Scientific, Rockford, 
IL, USA). 
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5.2.1.3 RNAi knockdown of CK2 
CK2A1, CK2A2, and CK2B siRNAs were obtained from Dharmacon RNAi 
Technologies (Thermo Fisher Scientific, Lafayette, CO, USA). Two µl of 10 µM siRNA and 0.5 
µl Lipofectamine RNAiMAX (Life Technologies, Carlsbad, CA, USA) were mixed in 50 µl of 
Opti-MEM medium (Life Technologies, Carlsbad, CA, USA). HeLa cells (2 x 10
6
) expressing 
Syn-GFP or mRFP-Ub were resuspended in 0.6 mL of Dulbecco’s modified Eagle’s medium 
(Life Technologies, Carlsbad, CA, USA) supplemented with 10% FBS, and added to each siRNA 
mixture. For proteasome inhibition treatment, the cells were incubated with 2 µM of MG 132 at 
48 h after transfection for 4 h.  
5.2.1.4 Aggresome counting 
Fluorescent microscopy was performed at room temperature with an Axiovert 200 (Carl 
Zeiss, Germany) microscope using a 100x objective and the manufacturer’s AxioVision 4 
software. To assess the fraction of cells with aggresomes, the cells were randomly counted in 
multiple fields to have more than 200 cells in total. Each experiment was repeated two times to 
assure reproducibility of the results. 
5.2.2 Results 
5.2.2.1 Knockdown of CK2 impacts the formation of aggresome 
We first performed immunoblotting to confirm that CK2 subunits are associated with 
Synphilin-1. The results are shown in Figure 5-1A. In contrast to the negative or neutral results 
we obtained for the α and α' subunits of CK2, the immunoblotting analyses showed that the CK2 
β subunit specifically binds to Synphilin-1. The CK2 α subunit did not bind to Synphilin-1. It was 
not possible to determine whether the CK2 α' subunit was associated with Synphilin-1, since this 
subunit binds to affinity tags non-specifically.  
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To investigate functional involvement of CK2 on the formation of Synphilin-1 
aggresome, we knocked down each subunit (α, α’, and β) separately in Syn-GFP HeLa cells using 
RNA interference (Figure 5-1B). As shown in Figure 5-1C, naïve cells did not form aggresomes 
(left panel). After 5-h MG 132 incubation, aggresomes formed in control cells (middle panel, red 
arrows). In contrast, aggresomes were not found in CK2 β depleted cells (right panel). 
Quantitatively, depletion of CK2B significantly reduced aggresome formation while depletion of 
CK2A1 or CK2A2 did not have a significant impact on aggresome formation (Figure 3-5D, blue 
columns), thus indicating that only CK2 β subunits are involved in regulation of aggresome 
formation. Furthermore, these data indicate that this process does not require the kinase activity 
of CK2. In order to determine whether depletion of CK2 β permanently or temporarily suppressed 
the formation of aggresome, we performed a time course MG 132 incubation, which showed that 
CK2B knockdown significantly delays aggresome formation, for up to 12 h. However, the 
difference between control and siCK2B knockdown cells, in terms of percentage of cells with 
aggresome, diminished after 24-h MG 132 incubation (Figure 5-1E). This result demonstrates that 
depletion of CK2 β delays, but does not eliminate, Synphilin-1 aggresome formation. 
In addition to formation of a Synphilin-1 aggresome, endogenous abnormal proteins can 
form aggresomes upon proteasome inhibition
174
.  Poly-ubiquitin can be attached to abnormal 
endogenous proteins and direct them to the proteasome for degradation. Therefore, ubiquitin can 
be used as an indicator to track abnormal protein aggregates. We have used RFP-Ubiquitin (RFP-
Ub) in HeLa cells to detect aggresome formation by endogenous abnormal proteins upon 
proteasome inhibition
98
. Here, we knocked down each CK2 subunit separately in RFP-Ub HeLa 
cells, and used RNA interference to investigate the CK2 regulation on the formation of 
endogenous aggresome. Similar to results obtained with the Synphilin-1 aggresome, depletion of 
CK2 α or α' subunits did not have an impact on aggresome formation by endogenous abnormal 
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proteins (Figure 5-1D, red columns). In contrast, CK2 β knockdown eliminated targeting of the 
ubiquitinated protein aggresome during 5-h MG 132 incubation (Figure 5-1D, red columns). 
Aggresomes started forming after 9-h MG 132 incubation in siCK2B knockdown cells, but the 
percentage of cells with aggresome was significantly different from that in control cells (Figure 5-
1F). However, the difference between the control and siCK2B knockdown cells, in terms of 
percentage of cells with aggresome, diminished after 24-h MG 132 incubation (Figure 5-1F). In 
summary, these data indicate that CK2B is involved in both the aggresome formation processes 
by Synphilin-1 and the ubiquitinated proteins. We also found that the kinase activities of CK2 are 
not critical for producing the CK2β effect on aggresome formation, since depletion of α or α’ 
catalytic subunits did not affect formation of these types of aggresome. 
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Figure 5-1. Knockdown of CK2 affects formation of aggresome. A. Immunoblotting showed 
that the CK2 β subunit specifically binds to Synphilin-1. In contrast, the CK2 α subunit did not 
bind to Synphilin-1, while CK2 α’ seemed to bind to affinity tags non-specifically. B. 
Knockdown efficiency of CK2A1, CK2A2, and CK2B subunits. C. Fluorescent micrograph of 
HeLa-Ub cells. Naïve cells (left) had ubiquitinated protein aggregates distributed around the cells. 
Aggresomes were formed in cells after treatment with 2 µM of MG 132 for 5 h (middle). No 
aggresome was formed in CK2 β depleted cells after treatment with 2 µM of MG 132 for 5 h 
(right). D. Knockdown of CK2B inhibited the formation of both Synphilin-1 and ubiquitin 
aggresomes, while knockdown of CK2A1 and CK2A2 did not have an effect on the formation of 
aggresomes. E. Time course of MG132 incubation of knockdown CK2B cells showing that 
knockdown of CK2B delayed the formation of a Synphilin-1 aggresome.  F. Time course of 
MG132 incubation of knockdown CK2B cells showing that knockdown CK2B delayed the 
formation of an endogenous ubiquitinated protein aggresome.  
5.2.3 Discussion 
CK2 seems to play a central role in Synphilin-1 interaction networks (Figure 3-4B). 
Immunoblotting detected that CK2 β is associated with Synphilin-1. CK2 phosphorylates 
Synphilin-1 and regulates the binding between Synphilin-1 and α-synuclein108. It has been 
reported that inhibition of CK2 activity blocks the binding between Synphilin-1 of α-synuclein 
and significantly reduces cytoplasmic inclusions. In contrast, our results showed that depletion of 
α or α’ subunits did not reduce aggresome formation. These results suggest that kinase activity of 
CK2 is not crucial for formation of aggresomes.   
In addition, CK2 is involved in regulation of the transportation of protein aggregates. 
Abnormal protein aggregates are transported through microtubules by dynein motors to form 
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aggresomes. It has been reported that CK2 phosphorylates HDAC6 and thereby affects the 
interaction between HDAC6 and dynein, which has an impact on the transportation of 
ubiquitinated protein aggregates
175
. CK2 is a microtubule-associated protein that confers 
microtubule stability in a phosphorylation-independent manner
176
, although CK2 also increases 
phosphorylation of tubulin
177
. Taken together, our results and previous publications show that 
CK2 plays an important role in aggresome formation. Further investigation of the CK2 regulation 
of aggresome formation will help to reveal the cellular mechanism of this process. 
5.3 Synphilin-1 in autophagy 
Autophagy is a catabolic process involving the degradation of a cell’s own components 
through the lysosomal machinery. The autophagy pathway has two steps (Figure 5-2). First, the 
materials to be degraded are enclosed by an isolation membrane to form an autophagsome. 
Second, the autophagosome fuses with the lysosome to form an autolysosome, where the protein 
aggregates are degraded into amino acids. There are two types of autophagy, basal autophagy 
occurring under normal cell conditions and inducible autophagy as observed in cells undergoing 
certain stresses, such as starvation. Autophagy is a highly regulated process involving the 
coordinated action of a large number of proteins encoded by Atg (autophagyrelated) genes
178
. 
Recent studies have shown that autophagy is induced in response to oxidative stress or 
proteasome impairment and participates directly in the clearance of aggresomes
178a, 179
. The 
aggresome–autophagy pathway is increasingly recognized as a key cellular system for defense 
against the accumulation of misfolded and aggregated proteins when the proteasome is 
overwhelmed or impaired
87a, 180
. However, autophagy-mediated clearance of aggresomes is not a 
universal phenomenon, but a selective phenomenon influenced by the protein composition of 
aggregation-prone inclusions
181
. For example, autophagy induction significantly reduces the 
number of aggresome-like inclusions generated in cells expressing mutant Htt, mutant tau and α-
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synuclein/Synphilin-1
181
. In contrast, autophagy induction has no apparent effects on the number 
of inclusions generated in cells expressing AIMP2 (p38) and mutant desmin, in which the cell 
death is due to failing to recruit key components of the autophagic/lysosomal system
181
. However, 
these “autophagy-resistant” aggresomes could be rendered “autophagy-susceptible” by mixing 
with “autophagy-susceptible” proteins, which suffice to recruit the autophagic machinery. As an 
“autophagy-removable” protein, small aggregates of Synphilin-1 are constitutively cleared by 
basal autophagy while the Synphilin-1 aggresome can only be removed by inducible autophagy
182
. 
As mentioned above, the formation of small aggregates of Synphilin-1 is determined by the CC 
and ANK2 domain, while the formation of aggresomes requires the ANK1 domain
98
.  Synphilin-1 
small aggregates can be removed by basal autophagy while Synphilin-1 aggresomes can only be 
removed by inducible autophagy
182
. The ANK1domain is responsible for efficient autophagic 
removal of Synphilin-1 protein inclusions and ANK1 domain facilitates recruitment of 
autophagic-lysosomal compartment to aggresome and aggregates
182
. K63 ubiquitination is 
required for aggresome removal by inducable autophagy, but not for degradation of aggregates by 
basal autophagy
182
. Decreasing cytosolic inclusions by stimulating autophagy constitutes a new 
therapeutic strategy for Parkinson disease. Several autophagy factors were found to be associated 
with Synphilin-1 in tandem affinity purification followed by immunoblotting, such as HDAC6, 
BAG3, and p62 (Figure 5-3). These results raise two questions that are should now be addressed: 
(a) does Synphilin-1 recruit these autophagy factors to aggresomes?, and (b) is Synphilin-1 
involved in autophagy? 
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Figure 5-2. Formation of autophagy. Adopted from Ref . (
183
).  
5.3.1 Experimental methods 
5.3.1.1 Chemicals and antibodies 
All chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) 
unless mentioned otherwise.  
Antibodies against HDAC6, BAG3, p62, and TDP43 were purchased from Abcam 
(Cambridge, MA, USA), Antibody against LC3 was from Cell Signaling (Danvers, MA, USA) 
the antibody against GFP was from Clontech (Palo Alto, CA, USA), and α-tubulin, and actin 
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
5.3.1.2 Immunoblot analysis 
The immunoblot analysis was performed as described in section 5.2.1.2.  
5.3.1.3 Cell cultures and immunohistochemistry 
HeLa cells expressing Syn-GFP were grown in Dulbecco’s modified Eagle’s medium 
(Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) at 
37 °C in an atmosphere of 5% CO2. Cells were transfected using Lipofectamine 2000 reagent 
(Life Technologies, Carlsbad, CA, USA) with depletion 6 of Synphilin-1, according to the 
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manufacturer’s instructions. For proteasome inhibition, 48 h after transfection, cells were 
incubated with 5 µM of MG132 (Biomol, Plymouth Meeting, PA) for varies time.  For analysis 
with a fluorescence microscope, cells were grown on Lab-TekTM chambered coverglass (NUNC, 
Rochester, NY, USA) pretreated with poly-L-lysine. At the end of proteasome inhibition, cells 
were fixed with 4% formaldehyde for 10 minutes, and then washed with PBS. The cells were 
incubated with primary antibodies for 1 h at room temperature, washed with PBS three times, and 
then incubated with secondary antibodies for another hour at room temperature. Then, DAPI were 
used to treat each set of cells to label the nuclei. Fluorescent microscopy was performed at room 
temperature with an Axiovert 200 (Carl Zeiss, Germany) microscope using a 100x objective and 
the manufacturer’s AxioVision 4 software. Three channels were used: Texas red for antibodies, 
FTIC for Syn-GFP, and blue for DAPI labeled nucleus. 
5.3.1.4 RNAi knockdown of Synphilin-1 and autophagy 
Synphilin-1 siRNAs were obtained from Dharmacon RNAi Technologies (Thermo Fisher 
Scientific, Lafayette, CO, USA). Two µl of 10 µM siRNA and 0.5 µl Lipofectamine RNAiMAX 
(Life Technologies, Carlsbad, CA, USA) were mixed in 50 µl of Opti-MEM medium (Life 
Technologies, Carlsbad, CA, USA). HeLa cells (2 x 10
6
) expressing Syn-GFP was resuspended in 
0.6 mL of Dulbecco’s modified Eagle’s medium (Life Technologies, Carlsbad, CA, USA) 
supplemented with 10% FBS, and added to each siRNA mixture. For measurement of starvation-
induced autophagy, cells were first incubated with PBS for 6 h. For proteasome inhibition 
treatment, the cells were incubated with 2 µM of MG 132 at 48 h after transfection for 4 h. 
Chloroquine treatment was used as positive control for LC3-I/LC3-II conversion since 
chloroquine is an agent that impairs lysosomal acidification that can block the turnover of LC3-II. 
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5.3.2 Results and discussion 
p62 is an autophagy factor that can recognize and deliver polyubiquitinated, misfolded, 
aggregated proteins and dysfunctional organelles for their clearance through autophagy. We used 
immunohistochemistry to determine whether p62 co-localizes with Synphilin-1. As shown in 
Figure 5-4, after 3 h of proteasome inhibition, small protein aggregates were formed in cells, and 
p62 co-localized with Synphilin-1 in these small aggregates. After 5 h of proteasome inhibition, 
aggresomes were formed in cells, and p62 co-localized with Synphilin-1 in these aggresomes. 
This indicates that Synphilin-1 associates with p62 in both aggregate and aggresome. We also 
checked the co-localization of other proteins with Synphilin-1, such as BAG3 and TDP43. In 
contrast, BAG3 (Figure 5-5) and TDP43 (data not shown) did not co-localize to Synphilin-1 in 
either aggresome or aggregates. 
Although the ANK1 domain is required for removal Synphilin-1 aggregates and 
aggresome by autophagy and recruitment of some autophagy factors, such as LAMP1, ANK1 is 
not required for p62 recognition and is not required for autophagic clearance of ANK1 containing 
aggresomes
182
. This possibly occurs because p62 is involved in clearance of not only 
ubiquitylated substrates
184
 but also non-ubiquitylated substrates
185
 by autophagy.  
LC3 is used as an autophagsome marker to assess autophagsome numbers, because LC3-I 
can bind to the autophagsome and conjugate with a PE (phosphatidylethanolamine) group to 
become LC3-II. The conversion from endogenous LC3-I to LC3-II can be detected by 
immunoblotting with antibodies against LC3
183
. Therefore, autophagy flux can be monitored by 
measurement of the ratio between LC3-I and LC3-II. To investigate effect of Synphilin-1 on 
basal autophagy, Synphilin-1 was knocked down in HeLa cells, with and without proteasome 
inhibition, by incubation with MG132. The results are shown in Figure 5-6. For basal autophagy, 
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MG132 inhibition increased basal autophagy by 60% in the control sample. Similarly, MG132 
inhibition also increased basal autophagy by 60% in the Synphilin-1 knockdown sample. This 
indicates that proteasome inhibition facilitates basal autophagy, independent to Synphilin-1. 
Comparison between control and Synphilin-1 knockdown samples shows that Synphilin-1 
knockdown increased basal autophagy by 40%, with or without MG132 treatment. This may 
occur because expression of Synphilin-1 enhances the formation of protein aggregates, and this 
facilitates basal autophagy to remove these aggregates. For starvation induced autophagy, MG132 
also increased inducible autophagy by 60% in both control and Synphilin-1 knockdown samples. 
In contrast to basal autophagy, synphililn-1 knockdown decreased inducible autophagy about 
20%, with or without treatment. This result indicates that Synphilin-1 may be involved in 
inducible autophagy.  
 
Figure 5-3. Several autophagy factors were found to be associated with Synphilin-1. 
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Figure 5-4. p62 co-localized with Synphilin-1 in both aggregates and aggresomes. 
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Figure 5-5. BAG3 does not co-localize with Synphilin-1 in both aggregates and aggresomes. 
 
Figure 5-6. Effects of proteasome inhibition and Synphilin-1 knockdown on basal and 
starvation induced autophagy autophagic fluxes. For basal autophagy, MG132 also increased 
inducible autophagy by 60% in both control and Synphilin-1 knockdown samples. Comparison 
between control and Synphilin-1 knockdown samples shows that Synphilin-1 knockdown 
increased basal autophagy by 40%, with or without MG132 treatment.  For starvation-induced 
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autophagy, MG132 also increased inducible autophagy by 60% in both control and Synphilin-1 
knockdown samples. In contrast to basal autophagy, synphililn-1 knockdown decreased inducible 
autophagy by about 20%, with or without treatment. 
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Chapter 6 : Conclusions & future perspectives 
Chapter 2 describes a methodology for performance of top-down mass spectrometry in 
combination with chemical cross-linking that has been successfully applied to study the 
intersubunit-cross-linking of human hemoglobin and TTR. The cross-linking sites of hemoglobin 
subunits were identified using top-down CID fragmentation and the results were consistent with 
reported crystal structures of hemoglobin. Future research will focus on pre-fractionation to 
enrich the cross-linked species, and thereby to reduce or eliminate ion suppression effects from 
the highly abundant mono-linked species. Sodium-free cross-linking reaction buffers are under 
evaluation, because the presence of sodium ions in the samples can reduce the MS signal through 
an increase in the surface tension of the spray droplets, which results in a reduction of volatility 
under ESI conditions. Use of other fragmentation methods, such as ETD and ECD, for top-down 
cross-linking is also under investigation. Applications to the study of folding disorders that 
involve both wild-type TTR (senile systemic amyloidosis, SSA) and its variants (familial 
amyloidotic polyneuropathy, FAP or transthyretin-related amyloidosis, ATTR) are planned. 
Chapter 3 describes development of tandem affinity purification in combination with 
label-free quantitative proteomics to study Synphilin-1 interactors. Fifty seven Synphilin-1 
enriched proteins have been identified. Functional enrichment analysis and IPA analysis of these 
proteins have been performed to reveal the pathways in which they are involved and provide hints 
for the biological functions of Synphilin-1 and the mechanism behind formation of protein 
aggregates and aggresomes. The results also provide a list of proteins for further biochemical 
assays to investigate their functions in the formation of aggresome and autophagy clearance of 
aggresomes. In addition, this protein list provides a database for investigation of Synphilin-1 
direct interactors using chemical cross-linking in combination with mass spectrometry, as 
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described in chapter 4. Future research is focused on studying the functions of identified 
Synphilin-1 interacting proteins involved in aggresome formation using biochemical assays. 
Chapter 4 reports the results of analyses performed as a consequence of the results 
described in chapter 3. A methodology for isotopically labeled cross-linking in combination with 
mass spectrometry was developed to study Synphilin-1 binary interactors, based on the fifty-
seven Synphilin-1 interacting proteins identified in Chapter 3. Using this approach, 17 novel 
direct interacting protein partners of Synphilin-1 were found, and the region containing the 
coiled-coil domain (CC) and ankyrin-like repeat domain 2 (ANK2) of Synphilin-1 was revealed 
as the main region that bound interacting proteins. The proteins found to be cross-linked are 
mainly involved in RNA metabolism, indicating that Synphilin-1 may participate in RNA 
processing. Together with information on the role of Synphilin-1 in aggregate/aggresome 
formation, these results suggest that a mechanism for Synphilin-1 regulation on abnormal protein 
expression, through RNA processing in response to cellular stresses, such as proteasome 
inhibition. Further research should include validation of Synphilin-1 interacting proteins using co-
IP. Conducting chemical cross-linking in Synphilin-1 living cells could reduce the occurrence of 
any non-specific cross-linking that may have resulted from breaking down of cell organelles 
during cell lysis. Further investigation of the involvement of Synphilin-1 in RNA metabolism is 
strongly recommended. The identified Synphilin-1 binary interacting proteins should be 
investigated with regard to their functions in aggresome formation. 
Chapter 5 reports on a further investigation of several Synphilin-1 interacting proteins 
that were identified in chapters 3 and 4. Since CK2 is a central hub of the Synphilin-1 interacting 
network that was determined in chapter 3, the effects of CK2 in aggresome formation were 
studied. Depletion of CK2 regulatory β subunits significantly reduced aggresome formation. In 
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contrast, knockdown of α or α’ subunits responsible for its catalytic activity did not affect 
aggresome formation. These results indicate that CK2 is an important regulator of aggresome 
formation but it does not regulate via its phosphorylation activities. The involvement of 
Synphilin-1 in autophagy was also studied since several autophagy factors have been found to be 
associated with Synphilin-1. The autophagy cargo-recognition protein, p62, co-localized with 
Synphilin-1 in both small aggregates and aggresomes. In addition, knockdown of Synphilin-1 
increased basal autophagy by 40% whereas it decreased starvation-induced autophagy by 20%. 
The results reported in this thesis should help to elucidate the molecular functions of 
Synphilin-1, and thus may lead to better understanding of aggresome formation and the 
development of Parkinson disease. They should thereby illuminate the path for development of 
therapeutics useful for treatment of neurodegenerative disorders.  
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